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1Summary
Summary
Post-embryonic neurogenesis relies on the presence of neural stem cells, which are characterized by 
their multipotency and unique ability to self-renew. Despite their importance for the homeostasis and 
repair of the central nervous system, the transcriptional network governing stemness in adult neural 
stem cells is largely unknown.
We established the transcription factor Rx2 as proxy for retinal stem cells in the post-embryonic retina 
of the teleost medaka (O. latipes). By interrogating the regulatory input to the Rx2 cis-regulatory 
element, we identified four transcription factors (Sox2, Tlx, Gli3, Her9), which distinctly shape the stem 
cell domain and modulate stem cell features in the retina. First of all, we analyzed the gene expression 
and found that these genes have distinct spatio-temporal expression patterns in the retinal stem cell 
domain. Conditional mosaic analysis in vivo confirmed Sox2 and Tlx as activators of Rx2. The ectopic 
expression of Sox2 or Tlx was sufficient to trigger de-differentiation of post-mitotic neurons and induced 
stem cell features therein. Conversely, sustained ectopic expression of Gli3 or Her9 repressed Rx2. 
Gain of Gli3 or Her9 in retinal stem cells arrested cell cycle progression and proliferation. Modification 
of conserved binding sites in the Rx2 cis-regulatory element revealed the importance of Sox and Gli 
transcription factors for the precise spatial Rx2 expression in retinal stem cells. We propose that the 
combinatorial regulatory input of Sox2, Tlx, Gli3, Her9 confines Rx2 expression and other features of 
retinal stem cells specifically to the periphery of the stem cell domain in the post-embryonic retina.
To elucidate the functional role of Rx2 itself, mutants were established with the aid of targetable 
nucleases. Transcription activator-like effector nucleases were employed to induce double-strand 
breaks specifically in the Rx2 coding sequence, which in the case of erroneous non-homologous 
end-joining created sequence alterations at the site of cleavage. The generation of stable, heritable 
mutations in the endogenous Rx2 locus described here opens the opportunity for future genetic studies 
of Rx2 in medaka.
2Zusammenfassung
Zusammenfassung
Postembryonale Neurogenese ist abhängig von der Präsenz von neuralen Stammzellen, die sich durch 
ihre Multipotenz und einzigartige Fähigkeit der Selbstteilung auszeichnen. Trotz deren Rolle für das 
Gleichgewicht und die Erneuerung des zentralen Nervensystems ist das transkriptionelle Netzwerk, 
welches Stammzellfähigkeiten von adulten neuralen Stammzellen reguliert, größtenteils unbekannt. 
Wir etablierten den Transkriptionsfaktor Rx2 als Marker für Stammzellen in der postembryonalen 
Netzhaut des Japanischen Reisfischs (O. latipes). Durch die Untersuchung des regulatorischen 
Elements von Rx2 identifizierten wir vier Transkriptionsfaktoren (Sox2, Tlx, Gli3, Her9), die die 
Stammzelldomäne formen und Stammzelleigenschaften in der Netzhaut modulieren. Als erstes 
analysierten wir die Genexpression und fanden heraus, dass diese Gene individuelle zeitliche und 
räumliche Expressionsmuster in der Stammzelldomäne der Netzhaut besitzen. Konditionale mosaische 
Analyse in vivo bestätigte Sox2 und Tlx als Aktivatoren von Rx2. Die ektopische Expression von 
Sox2 oder Tlx war ausreichend, um die Dedifferenzierung von Neuronen einzuleiten und in diesen 
Stammzelleigenschaften hervorzurufen. Umgekehrt reprimierte anhaltende ektopische Expression 
von Gli3 oder Her9 Rx2. Gli3 oder Her9 in Stammzellen der Netzhaut hemmte den Fortschritt im 
Zellzyklus und Proliferation. Modifizierung von konservierten Bindestellen im Rx2 regulatorischen 
Element enthüllte die Bedeutsamkeit von Sox- und Gli-Transkriptionsfaktoren für die präzise räumliche 
Expression von Rx2 in Stammzellen der Netzhaut. Wir schlagen vor, dass der kombinierte regulatorische 
Einfluss von Sox2, Tlx, Gli3 und Her9 die Expression von Rx2 und anderen Stammzelleigenschaften 
spezifisch in die Peripherie der Stammzelldomäne in der postembryonalen Netzhaut begrenzt. 
Um die funktionelle Rolle von Rx2 aufzuklären, wurden Mutanten mit der Hilfe von gezielten 
Nukleasen etabliert. Die spezifschen Nukleasen wurden benutzt, um Doppelstrangbrüche gezielt 
in der Sequenz von Rx2 zu erzeugen, die im Falle von fehlerhaften DNA Reparaturmechanismen 
zu Sequenzveränderungen an der Schnittstelle führten. Die Erzeugung von stabilen, vererbbaren 
Mutationen im endogenen Rx2 Genlocus, die hier beschrieben werden, eröffnet die Möglichkeit für 
zukünftige genetische Studien über Rx2 im Japanischen Reisfisch.
   INTRODUCTION
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1 Introduction
1.1 The vertebrate eye
1.1.1 Architecture of the vertebrate retina
Of all tissues that constitute the CNS, the eye represents the most accessible part and a well-studied 
paradigm for the process of neurogenesis and cell determination.
The stereotypic spatial composition of the neural retina (NR), six types of neurons and one type of 
glia distributed in three nuclear layers interconnected by two synaptic layers, is conserved amongst 
vertebrates (Livesey and Cepko 2001). The ganglion cell layer (GCL) is located at the basal side of 
the retina and contains the cell bodies of displaced amacrine cells (ACs) and retinal ganglion cells 
(RGCs) (Figure 1). The axons of RGCs exit through an opening in the central retina, the so-called 
optic disc, and transmit visual stimuli through the optic nerve to their targets in the brain. ACs, bipolar 
cells (BPCs), horizontal cells (HCs) and Muller glia cells (MGCs), the only non-neural cell type in 
the retina, are found in the inner nuclear layer (INL). The processes of MGCs extend from the inner 
limiting membrane of the retina to the outer limiting membrane at base of the outer segments. The 
apical outer nuclear layer (ONL) is occupied by the cell bodies of cone and rod photoreceptors in radial 
arrangement. Neuronal processes occupy the space between each nuclear layer. Photoreceptor, 
bipolar and horizontal synapses are hosted in the outer plexiform layer (OPL), between the ONL and 
INL. The inner plexiform layer (IPL), which is located between the INL and the GCL, contains the 
synaptic connections of RGCs, BPCs and ACs. The NR is surrounded on its apical surface by the 
retinal pigmented epithelium (RPE), which serves as a shield, ensuring that light exclusively enters 
the eye through the lens (Figure 1B). When the light reaches the cone and rode photoreceptor outer 
segments below the RPE, a phototransduction cascade is triggered and information flows from the 
photoreceptors, to BPCs to RGCs, which send a response to the visual centers in the brain. The 
purpose of the RPE for the proper functionality of the NR extends beyond light and damage protection. 
Integrity of the RPE is required for normal development of photoreceptors and MGCs (Jablonski et al. 
2000; Jablonski et al. 2001). 
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Figure 1. Shape and composition of the vertebrate retina.
(A) Cross-section through the adult fish retina. Nuclei were counter-stained with DAPI. Red lines indicate apico-
basal axis of the nuclear layers. Dashed (red) lines indicate the apico-basal axis of the layers containing the cell 
bodies. The red areas at the margin represent the CMZ.
(B) Schematic representation of a magnified cross-section through the differentiated vertebrate retina. Apical 
side is up, basal side is down. Cone and rod photoreceptors are located in the ONL. They form synapses in 
the OPL with BPCs and HCs, which are located in the INL. Additionally, ACs are also found in the INL. RGC, 
positioned in the GCL, form synapses with ACs and BPCs in the IPL. MGCs span the entire apico-basal axis of 
the NR. Adapted from (Swaroop et al. 2010). 
1.1.2 Retinal neurogenesis
The sequence of neurogenesis during embryonic development of the retina has been extensively 
studied in a variety of species. The temporal order of generated cell types is highly conserved across 
all vertebrates (Livesey and Cepko 2001). A common population of multipotent retinal progenitor cells 
(RPCs), arranged in a pseudostratified neuroepithelium, proliferates and gives rise to all different retinal 
cells types in a sequential yet overlapping order. The first cells to be generated are RGCs, followed 
by HCs, cone photoreceptors, ACs, rod photoreceptors, BCs and MGCs. The timing of RPC cell cycle 
exit is closely linked to cell fate the progeny adopt in retinal differentiation (Livesey and Cepko 2001; 
Marquardt and Gruss 2002; Cremisi et al. 2003). For instance, early cell cycle exit is associated with an 
over-production of early cell types at the expense of late cell types, while delayed cell cycle exit results 
in additional rounds of division and a reduction in early born cell types (Ohnuma et al. 2002; Dyer 
et al. 2003). During a process called interkinetic nuclear migration, the nuclei of retinal progenitors 
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move between the apical and basal surfaces of the neuroepithelium depending on the current phase 
of cell cycle. DNA synthesis (S-phase) takes place at the basal (vitreal) side, while mitotic nuclei 
(M-phase) are located apically (Del Bene 2011). It has been suggested that the plane of cell division 
relative to the apical surface of the neuroepithelium influences the outcome of cell divisions. During the 
genesis of RGCs in the developing zebrafish retina, circumferential divisions are more likely to produce 
asymmetric fates, such as one RGC and one non-RGC, while radial divisions generate symmetric 
fates with a higher frequency, both daughter cells committing to ganglion cell fate (Poggi et al. 2005).
An extensive number of cell lineage studies have proofed the mutipotency of retinal progenitors, 
(Turner and Cepko 1987; Holt et al. 1988; Wetts and Fraser 1988). The finding that RPC derived 
clones can vary greatly in size and composition, implicates a role for stochasticity in cell fate decisions 
controlling the balance between proliferation and differentiation (Wong and Rapaport 2009; He et al. 
2012). Instead of different lineage-restricted progenitor cells producing different differentiated cells, it 
has been demonstrated that RPCs are restricted to make temporally appropriate cell types only. As 
shown in heterochronic transplantations, where RPCs from a particular time window are exposed to 
an younger or older environment, extrinsic cues from the environment are able to alter the relative 
proportions of each cell type generated at a particular time, but they cannot dictate the commitment 
towards a specific fate (Watanabe and Raff 1990; Austin et al. 1995; Belliveau and Cepko 1999; 
Belliveau et al. 2000). Progenitors pass progressively through a series of competence states, during 
each of which the progenitors are competent to produce a subset of retinal cell types (Livesey and 
Cepko 2001). This feature, that the sequence of cell birth is intrinsically determined in the progenitors 
cells, is similar to other lineages of the CNS, such as developing cerebral cortex (Qian et al. 2000). In 
addition to being multipotent, undifferentiated retinal precursors have been demonstrated to give rise 
to both NR and RPE in the retina of medaka (Centanin et al. 2011).
1.1.3 The ciliary marginal zone
Tissue growth and homeostasis during development and adulthood are fundamental features of all 
vertebrate species. In the CNS, both cell replacement and cell addition depend on newborn neurons 
being generated by neural stem cells (NSCs). NSCs have the ability to self-renew infinitely and 
contribute differentiated progeny to both neural and glial lineages, which will be integrated in the 
established circuitry.
Whereas the existence of adult NSCs in the mammalian brain has been confirmed in the subventricular 
zone of the lateral ventricles and the subgranular zone of the dentate gyrus in the hippocampus (Lois 
and Alvarez-Buylla 1993; Kuhn et al. 1996), the NR of mammals is considered to be a post-mitotic 
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tissue (Amato et al. 2004). In contrast, the non-mammalian retina contains a reservoir of mitotically 
active cells after conclusion of initial retinogenesis. This stem cell domain, the ciliary marginal zone 
(CMZ), is spatially separated from post-mitotic cells and situated at the periphery of the retina (Figure 
1A). Birth dating studies in lower vertebrates (frog and fish) have implicated the CMZ as the source 
of post-embryonic neurogenesis, which provides new neurons and glia to accommodate the life-long 
growth of the NR (Hollyfield 1968; Straznicky and Gaze 1971; Johns 1977). It has been suggested 
that the spatial distribution of the CMZ, from peripheral to central, reflects the temporal progression 
of embryonic retinogenesis (Harris and Perron 1998; Perron and Harris 2000). Slowly dividing retinal 
stem cells (RSCs) reside in the peripheral-most part of the CMZ, which give rise to short-term rapidly 
dividing progenitors (Figure 2A). These transiently amplifying progenitors are located more centrally. 
Cells in the CMZ, which are found closest to differentiated neurons, do not divide and in terms of 
gene expression resemble committed RPCs. Interestingly, in vitro studies have demonstrated that cells 
derived from the pigmented ciliary margin of mice, which is a domain topographically comparable to 
the non-mammalian CMZ, proliferate and form neurosphere colonies in culture (Tropepe et al. 2000). 
Lineage tracing analysis has identified bona fide multipotent RSCs in the medaka CMZ (Centanin et 
al. 2011). Single-cell-derived clones consist of all seven cell types, which comprise the vertebrate NR. 
Moreover, in the life-long growing medaka retina, post-embryonic stem cells maintain the simultaneous 
expansion of NR and RPE (Figure 2B-C). In frog and fish, the compartmentalized proliferation and 
addition of new cells occurs in the marginal domain of the RPE, which covers the CMZ (Perron et al. 
2003). Thus, the post-embryonic medaka retina constitutes an excellent model to investigate adult 
NSCs. 
It is currently unknown when the stem cell domain is established during development. The extracellular 
and intracellular signals defining the ciliary margin in amphibians have been addressed through gene 
expression profiling and modulation of signaling cascades mostly at embryonic stages. A number of 
studies have suggested opposing roles for canonical Wnt and Shh signaling pathways in the regulation 
of undifferentiated retinal progenitors - Shh shortens the length of the cell cycle (Locker et al. 2006), while 
Wnt targets such as Hes4 lengthen the phases of the cell cycle (El Yakoubi et al. 2012). Furthermore, 
both pathways have been demonstrated to inhibit each other through their downstream mediators in 
the margin of the retina (Borday et al. 2012).
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Figure 2. Model of self-renewal in the fish retina.
(A) Regarding the growth of the NR in fish and frog, it has been proposed that slowly-cycling stem cells self-renew 
and generate rapidly dividing transient amplifying cells, which in turn give rise to differentiated cells (Locker et 
al. 2006).
(B-C) During the lifelong growth of the medaka retina, two tissues, the NR and the RPE, are independently 
maintained by individual RSCs located in the CMZ. Multipotent RSCs generate all seven cell types of the NR (B) 
or post-mitotic cells of the RPE (C). Descendents of each dedicated stem cell are either committed towards the 
NR- or RPE-lineage (Centanin et al. 2011).
1.1.4 Optic vesicle formation
Eye development begins at the end of gastrulation with the determination of the eye field, an epithelial 
eye precursor in the anterior neuroectoderm, simultaneously with the patterning of the prospective 
forebrain. Eye field specification requires the downregulation of Bmp signals, known inhibitors of a 
neural fate (Gestri et al. 2005). Similarly, findings in fish have indicated that beta-catenin-dependent 
Wnt signaling has to be repressed for the patterning of the anterior neural plate. It has been shown that 
Wnt8b-mediated ectopic activation of the canonical Wnt signal cascade antagonizes the specification 
process (Cavodeassi et al. 2005), while loss of wnt8 results in the reduction of posterior neuroectoderm 
and an expansion of forebrain structures and axial mesoderm (Lekven et al. 2001). The Zebrafish mutant 
masterblind, carrying a mutation in Axin1, lacks eyes and parts of the telencephalon, accompanied by 
an expansion of diencephalic tissue (Heisenberg et al. 2001; van de Water et al. 2001). 
Experimental data from Xenopus and zebrafish indicate the importance of activation of IGF signaling 
for patterning of the retinal anlage. Blocking of the pathway through dominant-negative IGF receptors 
interferes with CNS development, particularly with the formation of anterior neural structures, leading 
to reduction or loss of head and eye (Pera et al. 2001; Eivers et al. 2004).
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Following specification and patterning, the single retinal anlage is split into the two retinal primordia. 
Midline-derived signaling molecules, such as sonic hedgehog (Shh) and fibroblast growth factor (Fgf), 
are instructive for the split of the eye field and patterning of the laterally formed optic vesicles (Ekker 
et al. 1995; Macdonald et al. 1995; Chiang et al. 1996; Koster et al. 1997; Carl and Wittbrodt 1999).
The morphogenetic events occurring during optic vesicle evagination have been analyzed in detail 
through 4D microscopy at a single-cell level in medaka and zebrafish (Rembold et al. 2006; Keller 
et al. 2008). The evagination of optic vesicles is initiated during neural tube closure by individual 
cell migration towards the midline. Future RPCs converge slower in comparison to the surrounding 
future forebrain cells, resulting in the formation of a wider domain from which the vesicles will arise. 
Afterwards, outward-directed migration of RPCs leads to the splitting of the eye field. In the forming 
optic vesicle individual RPCs intercalate and promote formation of the vesicular epithelium.
1.2 Homeodomain transcription factors Pax6, Rx and Six3 play central 
roles in eye development
It has been suggested that Pax6, Rx and Six3 are part of a highly conserved genetic network, which 
directs the initiation of eye development, in particular the establishment of retinal identity in cells 
involved in morphogenesis of the optic vesicle (Halder et al. 1995; Oliver and Gruss 1997; Gehring 
and Ikeo 1999). Consistent with their proposed role in specification of retinal fate, ectopic expression 
of each of these factors during amphibian embryonic development results in mutual cross-activation 
and ectopic formation of retinal tissue (Mathers et al. 1997; Chow et al. 1999; Loosli et al. 1999; Zuber 
et al. 1999; Bernier et al. 2000). 
Loss of Pax6 is accompanied by defective optic vesicle formation and lens development, resulting 
in absent eyes (Jordan et al. 1992; Grindley et al. 1995). In the presumptive lens ectoderm, Pax6 is 
required for the inhibition of canonical Wnt signaling (Machon et al. 2010). Results from conditional 
inactivation implicated Pax6 in the maintenance of RPCs in a pluripotent state (Marquardt et al. 
2001). The expression of other early eye field specification markers Rx and Six3 were unaffected in 
conditional mutants, suggesting that the specific function of Pax6 in RPC proliferation is downstream 
or independent of these homeobox genes. Despite evidence that loss of Pax6 affects progenitor cell 
division, the molecular connection to the cell cycle remains unknown (Warren et al. ; Estivill-Torrus et 
al.). 
Similar to Six3, Rx expression starts in the anterior neuroectoderm and later continues in progenitor 
cells during optic cup development. Cross-species analysis has highlighted early Rx function as a 
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crucial influence on steps of optic vesicle morphogenesis, convergence and evagination. In Xenopus, 
fish and mouse, inactivation of Rx is accompanied by reduced eye size or complete absence of eyes 
(Mathers et al. 1997; Andreazzoli et al. 1999; Loosli et al. 2001; Loosli et al. 2003; Kennedy et al. 
2004). This conservation is underscored by findings that Rx is mutated in humans with anopthalmia 
(Voronina et al. 2004). 
The medaka and zebrafish genomes contain three Rx genes, of which Rx3 is expressed the earliest in 
the early eye field (Loosli et al. 2001; Loosli et al. 2003). 
The role of Rx3 in eye morphogenesis was further elucidated by in vivo imaging analysis, which 
showed that mutant cells converge fully towards the midline but fail to migrate outwards to form the 
optic vesicles (Rembold et al. 2006). Analysis of the underlying molecular mechanism revealed that 
Rx3 down-regulates expression of the Ig-domain protein Nlcam, which modulates the migration of 
progenitor cells during the initial phase of midline convergence (Brown et al. 2010).
The function of Rx1 and Rx2, which are expressed following optic vesicle formation, is less clear. 
In zebrafish, morpholino oligonucleotide-mediated knockdowns failed to produce an early phenotype 
in the retina (Rojas-Muñoz et al. 2005). During later stages, expression of Rx1 is required for the 
proliferation and survival of retinal progenitors, while both Rx1 and Rx2 are involved in regulating the 
expression of photoreceptor-specific genes (Nelson et al. 2009). In Xenopus, Rx, in combination with 
other TFs, is necessary for proper photoreceptor maintenance and function by direct regulation of 
genes such as rhodopsin and red cone opsin (Pan et al. 2010). Furthermore, Rx has been shown to be 
important for proliferation and migration of RPCs (Kenyon et al. 2001; Zaghloul and Moody 2007). Rx 
directly regulates Otx2 expression, which is required for photoreceptor cell fate determination, mainly 
in the final cell cycle prior to terminal differentiation of RPCs in the embryonic mouse retina (Muranishi 
et al. 2011). These results hint at a conserved Rx function in photoreceptor specification. 
Rx transcription is upregulated as a response to injury in the retina of fish, while knockdown of Rx 
impairs wound healing in the frog retina (Raymond et al. 2006; Martinez-De Luna et al. 2011). In 
contrast to Pax6 and Six3, Rx expression continues following embryogenesis RSCs and RPCs. Rx1 
and Rx2 have been described as molecular markers for the post-embryonic CMZ in zebrafish and 
Xenopus (Locker et al. 2006; Raymond et al. 2006; Borday et al. 2012). Furthermore, Rx is expressed 
in the quiescent stem cells of the central NR, the MGCs, which have the ability to trans-differentiate 
upon injury (Bernardos et al. 2007). Notably, lineage-tracing experiments have highlighted Rx2 as a 
marker for multipotent stem cells in the post-embryonic medaka retina (L. Centanin and J. Wittbrodt, 
unpublished). Clones derived from Rx2-postive cells through both traditional transplantation assays 
and conditional genetic labeling (inducible CreERT2 expressed under the medaka Rx2 CRE) contained 
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all seven cell types of the NR. In addition, recombination triggered in Rx2-positve RSCs located in the 
CMZ, generated clones of epithelial cells in the RPE. Examination of the clone composition underscored 
that a pool of Rx2-positive stem cells maintains both tissues independently, since cell types of the RPE 
and NR have never been found in the same clone. However, the function of either paralog in the RSC 
domain remains unknown.
1.3 Transcriptional cues regulating Rx expression
The regulatory elements upstream of the Xenopus Rx genes have been isolated and shown to be 
capable of driving reporter expression in the developing eye and mature retina (Zhang 2003; Martinez-
De Luna et al. 2010). Detailed examination of the regulatory organization highlighted the importance 
of upstream trans-acting factors Otx2 and Sox2 for direct activation of the Xenopus Rx cis-regulatory 
element (CRE) (Danno et al. 2008), and implied the involvement of other factors such as Pou and 
forkhead TFs in the transcriptional regulation of Rx (Martinez-De Luna et al. 2010). Although a number 
of factors have been implicated in the upstream regulation of Rx, the exact molecular nature of their 
interaction and how they function on the CRE in vivo remains unknown. The isolated medaka Rx2 
CRE has been shown to drive reporter expression in RPCs (Martinez-Morales et al. 2009), faithfully 
recapitulating endogenous Rx2 expression during the optic cup development and later retinogenesis 
(Inoue and Wittbrodt 2011). The fact that Rx2 labels bona fide RSCs in vivo and the availability of the 
relatively short (2400 base pairs) CRE makes the retina-specific TF Rx2 an interesting candidate to 
elucidate the regulatory framework governing stemness in the adult fish retina.
1.4 Following mitotic lineages
To understand the contribution of an individual progenitor or stem cell to tissue growth or maintenance, 
all descendents coming from this single cell have to be investigated. Lineage represents the result 
of each cell division in a temporal order. Diverse lineage-tracing techniques have been established 
to address a variety of questions, from exploring the embryonic origin of different tissues, over how 
certain progenitors contribute to a tissue, to finding the cellular origin of cancer. Ideally, the techniques 
allow labeling of individual cell and examining cellular fate dynamics by reconstruction of an entire 
lineage at single-cell resolution. 
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1.4.1 Label-retaining assays
Stem cells that divide slowly or infrequently will incorporate a marker during S-phase such as DNA 
analogs (e.g., BrdU) or fluorescent histone labels (e.g., H2B-EGFP) following pulse labeling, and upon 
repeated cell division pass them on to their progeny. The dilution of the label can be used to track the 
fate of their daughter cells, which provides knowledge about the properties of the initially labeled stem 
cell population (Cotsarelis et al. 1990; Tumbar et al. 2004).
In model amenable to direct visualization of cell movements in high spatio-temporal resolution by light 
microscopy, lineages can be followed in vivo. Data obtained from the tracking of cell movements via 
fluorescently labeled chromatin over time has shed light on the mitotic lineages within key developmental 
processes, e.g., migration of retinal progenitors in the medaka anterior neuroectoderm, early zebrafish 
morphogenesis and the gastrulation in the fruitfly (Rembold et al. 2006; Keller et al. 2008; McMahon et 
al. 2008). Reconstruction of an entire lineage, by means of tracking cells via in vivo imaging analysis 
or in fixed samples, relies on the ability to clonally label the cell population of interest.
1.4.2 Cell transplantation
Transplantation assays, including the generation of interspecies chimeras or genetic mosaics, have 
been used extensively in developmental embryology to study cell fate in a clonal manner. Permanently 
labeled cells (e.g., fluorescent protein) transplanted into an unlabeled host present elegant ways to 
increase our understanding of tissue homeostasis and development, such as within the lung and retina 
(Giangreco et al. 2009; Centanin et al. 2011). However, non-permanent labels are prone to diffusion 
into neighboring cells (e.g., vital dyes) and quick turnover after successive rounds of cell division (e.g., 
fluorescent proteins provided by mRNA injections).
1.4.3 Genetic Recombination
In general, systems used for genetic recombination to achieve clonal labeling consist of two components: 
a recombinase and a genetically encoded conditional reporter gene. The two systems most commonly 
deployed are Flp/FRT and Cre/lox, derived from Saccharomyces cerevisiae and bacteriophage P1, 
respectively (Branda and Dymecki 2004). Reporter constructs, typically under control of an ubiquitously 
active regulatory element, constitute of a “default” cassette (transcriptional roadblock or fluorescent 
marker) flanked by target sites (e.g., lox2272) followed by the coding sequence for the desired genetic 
marker (e.g., fluorescent proteins or beta-galactosidase). Expression of a recombinase (e.g., Cre) in a 
cell-specific manner triggers site-specific recombination and expression of a conditional reporter gene, 
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ideally initializing life-long genetic labeling of all progeny of the marked cells. 
In the fruitfly Drosophila melanogaster cell lineage analysis is typically based on reporter constructs 
equipped with FRT-sites, which are recognized by the Flp enzyme (Harrison and Perrimon 1993). 
In mice the Cre/lox approach has become the most commonly employed recombination system. 
Constitutive, ubiquitous reporter expression is commonly achieved in mice by insertion into the 
Rosa26 locus (Srinivas et al. 2001). Chimeric Cre, fused to the human estrogen receptor (ER), provide 
accurate spatio-temporal control over the recombination event (Metzger et al. 1995a; Metzger et al. 
1995b). The ligand-dependent recombination, Cre translocation to the nucleus is only permitted in 
case of hormone binding, has been significantly improved in terms of efficiency and sensitivity with 
the advanced CreERT and CreERT2 recombinases (Feil et al. 1996; Feil et al. 1997). The system is 
modular by crossing different cell-specific drivers controlling the recombinase to the same transgenic 
reporter, in theory allowing temporal and spatial control over the recombination in any tissue. For 
monitoring specific events in signal cascades, the Cre activity can be coupled to post-translational 
specific modifications. For instance, when fused to extracellular domain of the Notch1 transmembrane 
receptor, Cre protein is free to enter the nucleus and mediate recombination strictly upon receptor 
proteolysis, specifically tracing descendents of cells exposed to Notch1 activation (Vooijs et al. 2007). 
In addition, the system is expandable by stacking differently colored fluorescent proteins between 
incompatible lox variants, resulting in stochastic recombination and uniquely labeled clones (Livet et 
al. 2007). The tamoxifen-inducible Cre enzyme has emerged as one of the most powerful tools in fate 
mapping, in particular for stem cell research concerning adult stem cells, since it allows visualizing the 
lineage potential of the (post-embryonically) induced cell population. Using the CreERT2, significant 
findings in the mice model have been made on cell fate dynamics in the interfollicular epidermis, 
germline, hair follicle, intestine and stomach (Barker et al. 2007; Clayton et al. 2007; Nakagawa et 
al. 2007; Barker et al. 2010; Snippert et al. 2010a). Concerning the CNS, an elegant study revealed 
nestin-positive radial glia-like precursors as self-renewing and multipotent NSCs in the adult mouse 
dentate gyrus (Bonaguidi et al. 2011). In medaka, the multipotency of Rx2-positive adult RSCs has 
been demonstrated with specific Cre expression under the Rx2 CRE at post-embryonic stages (L. 
Centanin and J. Wittbrodt, unpublished).
Recently, inducible genetic labeling offered potential solutions to the longstanding debate regarding 
the cellular origin of cancer. Lineage-tracing analysis of squamous skin tumors presents the first 
experimental evidence for the existence of cancer stem cells during unperturbed tumor evolution, 
independent of transplantation assays (Driessens et al. 2012). In another report examining the 
contribution of individual cells to tumor formation and growth in the mouse intestine, researchers 
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identified Lgr5-positive cells as the multipotent stem cells of adenomas (Schepers et al. 2012). Notably, 
this study took advantage of a reporter construct with inverted components and lox-sites facing each 
other, continuing to switch colors after the initial induction as long as tamoxifen is provided, a process 
termed re-tracing.
Applied in zebrafish, fate-mapping through recombination of genetic markers shed light on different 
processes, such as the development of the cornea and plasticity of cardiac lineages during regeneration 
(Pan et al. 2013; Zhang et al. 2013). Moreover, lineage-tracing contributed greatly to our understanding 
of stem cell behavior in growing or renewing tissues, and whether asymmetry exists at the level of 
individual stem cells or an entire stem cell population. In the past numerous studies showed individual 
stem cells divide asymmetrically, giving strictly rise to one daughter cell that retains stem cell identity, 
therefore argued for a fate pattern of invariant asymmetry maintaining tissue homeostasis. More 
recently, quantitative analyses of long-term progression of labeled clones suggest that the prevalent 
strategy for homeostasis in cycling tissues is achieved by population asymmetry, for instance in the 
mammalian epidermis and the intestine (Clayton et al. 2007; Snippert et al. 2010b). Rather than 
maintaining balance by strictly dividing asymmetrically, clones in these tissues can be partially or 
entirely lost due to terminal differentiation or injury, while others expand through symmetric division to 
compensate for their absence, a pattern similar to what has been described in the germline (Morrison 
and Kimble 2006). 
1.5 Reprogramming of terminally differentiated somatic cells
During the development of an entire organism, irreversible cellular identities are established and 
maintained in the embryo, all arising from undifferentiated pluripotent stem cells. It has been a long-
standing challenge to reverse terminally differentiated cells back into a stem cell-state.
Reprogramming by somatic cell nuclear transfer was first demonstrated by the generation of tadpoles 
and adult frogs from unfertilized oocytes that had received a nucleus from the epithelial cells of the 
adult intestine (Gurdon 1962b; Gurdon 1962a). More than 30 years later, based on the same principle, 
the first mammals were successfully cloned from differentiated cells, which still hold all of the required 
genetic informations needed for the development of entire organisms, while unfertilized eggs contain 
factors that can reprogram the nuclei of somatic cells (Wilmut et al. 1997; Wakayama et al. 1998).
Embryonic stem cells (ESCs), derived from the inner cell mass of a blastocyst, are characterized by their 
ability to self-renew indefinitely and differentiate into any of the three germ layers. Fused with somatic 
cells, ESCs are capable of forming pluripotent hybrids (Tada et al. 2001). Nuclear reprogramming in 
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cell hybrids proofed the plasticity of differentiated mammalian cells; their differentiated state can be 
reversed when they are fused with embryonic germ cells or ESCs (Tada et al. 1997).
Induced cell fate changes include de-differentiation of somatic cells into a stem cell-state, as well 
as trans-differentiation into another cell type. The idea of lineage-defining factors, single TFs that 
determine and induce the fate of a given lineage, stems from mis-expression experiments resulting 
in trans-differentiation. In Drosophila, ectopic expression of homeotic genes, such as Antennapedia 
or eyeless, was shown to be sufficient to induce the transformation of one body part into another 
(Schneuwly et al. 1987; Gehring 1996). The direct conversion of mammalian fibroblasts into myoblasts 
was achieved by forced expression of single TF, MyoD (Davis et al. 1987). 
Combining the observations from nuclear reprogramming through cell fusion and lineage-defining TFs 
led to the hypothesis that reprogramming of somatic cells back into the embryonic state is achieved 
by the presence of multiple factors in unfertilized oocytes or ESCs. Therefore, it was tested if the 
simultaneous expression of defined factors induces a de-differentiation of somatic cells. Yamanaka 
and colleagues identified the four TFs Oct4, Sox2, Klf4 and c-Myc as sufficient to reprogram mouse 
and human embryonic fibroblast cells back to a pluripotent state (Takahashi and Yamanaka 2006; 
Takahashi et al. 2007). Global expression analysis revealed that in these so-called induced pluripotent 
stem cells (IPSCs) large quantities of ESC-specific genes are reactivated and many epigenetic marks 
are removed. 
Recently, the first cellular reprogramming in vivo in genetically engineered mouse lines expressing 
the reprogramming TFs in an inducible manner was reported (Abad et al. 2013). Upon expression 
of Oct4, Sox2, Klf4 and c-Myc the mice developed teratomas, disorganized tissues containing cells 
representative of all three germ layers, across multiple tissues. When reprogrammed, IPSCs isolated 
from the bloodstream of transgenic mice were cultured, they adopted characteristics of trophoblast 
stem cells, indicating totipotency. 
The successful reprogramming of differentiated cells into IPSCs followed by directed differentiation 
into the desired cell type offers an attractive route to regenerate any damaged or missing tissue. An 
alternative approach is the direct reprogramming - switching from one somatic lineage to another - 
through the expression of a multiple lineage-specifying TFs. One of the first studies reporting successful 
direct reprogramming was the conversion of exocrine cells to endocrine cells in the mouse pancreas 
mediated by a combination of Ngn3, Pdx1 and Mafa (Zhou et al. 2008).
Combined expression of the TFs Brn2, Ascl1 and Myt1l was sufficient to directly reprogram mouse 
fibroblast cells and human IPS cells into fully functional neuronal cells (Vierbuchen et al. 2010; Pang 
et al. 2011). Recently, it was demonstrated that expression of a single TF, Sox2, is capable of inducing 
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NSC-characteristics in cultured mouse and human fibroblast cells (Ring et al. 2012). These induced 
NSCs resemble wild-type NSCs in their morphology, self-renewal, ability to form neurospheres, and 
gene expression profiles. Directly reprogrammed NSCs are self-renewing and multipotent, as they 
differentiate into several classes of mature neurons, as well as astrocytes and oligodendrocytes.
The freedom to generate patient-specific pluripotent stem cells provides new avenues for basic 
research and transplantation therapies with fully immunologically matched grafts for neurological 
and degenerative diseases. Moreover, cells could be manipulated for therapeutic purposes (e.g., cell 
replacement) towards a specific lineage, for instance a specific neuronal or glial cell type. 
1.6 Gene knockdown and knockout in developmental genetics
1.6.1 Forward genetics
A common approach to interrogate the biological function of genes is the analysis of the loss-of-
function phenotypes. In mutational analysis genes are functionally inactivated by disruptive mutations 
altering the protein-coding sequence, resulting in defective biological processes and the appearance 
of perceptible phenotypes. Alternatively, methods depleting mRNA transcript pool or interfering with 
translation or splicing allow functional characterization of genes without the necessity of introducing 
mutations into the genome. In addition, they allow studying the effect of knockdowns of multiple targets 
in one system, with the drawback that studies are limited to the early development.
Traditionally, most gene functions have been exposed in phenotype-based approaches, where 
arbitrary gene disruption is followed by identification of mutant phenotypes. Mutants are identified by 
their displayed phenotypes; as a consequence the altered allele is mapped within the genome and 
associated with the observed phenotypic changes. Forward genetic screens have been successfully 
carried out in model systems as diverse as flies, worms, fish and mice (Brenner 1974; Nüsslein-
Volhard and Wieschaus 1980; Hitotsumachi et al. 1985; Kubota et al. 1995; Driever et al. 1996; Haffter 
et al. 1996; Loosli et al. 2000). Base modifications resulting in heritable codon changes can be induced 
through ionizing radiation or chemical agents such as ENU or EMS, while transposase-mediated 
random insertions of transposable DNA elements provide a different method to cause disruption of 
extant coding sequences (Cooley et al. 1988; Gossler et al. 1989). 
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1.6.2 Reverse genetics
Teleost species medaka and zebrafish have become increasingly popular in biological research, in 
particular as resources in vertebrate developmental genetics. They are perfectly suited for large-scale 
forward genetic screens due their small size, accessibility and transparency. A large number of human 
disease genes have orthologs in medaka (more than 65%) and zebrafish (more than 75%), making 
both species amenable to disease-related genetic studies (Kasahara et al. 2007; Howe et al. 2013). 
While the forward genetic screen is a powerful tool for uncovering unknown gene functions of great 
diversity, a reason why this approach is of interest for research in models where targeted mutagenesis 
is available (Anderson 2000), it imposes a number of limitations. The gene discovery is phenotype-
driven and therefore relies on mutations that produce a visible phenotype. For instance, some mutations 
will lack an overt phenotype because of the existence of genes with redundant functions. Likewise, 
mutants can be missed during the screening process due to their subtle phenotype. Moreover, this 
approach is incapable of generating individual mutations at will for a specific gene of interest. This 
presents a general problem for model organisms such as fish and frogs, where the lack of reliable 
approaches mediating targeted mutagenesis has limited the functional analysis of genes.
1.6.2.1 Targeting induced local lesions in genomes
One application to bridge the gap between forward and reverse genetics in model organisms such as 
fish is targeting induced local lesions in genomes (TILLING). Pioneered in Arabidopsis thaliana, the 
initial steps of large-scale forward genetic screens based on random mutagenesis (e.g. chemically 
induced in sperm or spermatogonia) remain the same (McCallum et al. 2000; Colbert et al. 2001). 
However, instead of phenotypic selection, individual DNA samples are obtained for sequence-based 
selection beforehand. Prior knowledge of the genomic sequence is required for the gene-specific 
PCR amplification steps, which are followed by endonuclease treatment to uncover mismatches in 
complementary DNA strands. Once the existence of a mutation in the gene of interest is confirmed, 
phenotypic consequences can be analyzed in the corresponding mutant fish (Wienholds et al. 2002; 
Ishikawa et al. 2010). Reduced sequencing costs make whole genome sequencing comparison an 
attractive alternative approach to identify altered coding sequences. Recently, the combination of 
large-scale random mutagenesis and high-throughput sequencing identified mutations in more than 
38% of the protein coding zebrafish genes (Kettleborough et al. 2013). Large-scale genetic screens in 
fish remain relevant for the systematic identification of vertebrate gene function due to their ease and 
range; adding to their appeal is the possibility to pair them with rapid and cost-efficient sequencing 
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protocols in order to identify precisely the altered sequence in the genome.
1.6.2.2 Morpholino oligonucleotides
Exploring gene function in fish and frog based on reverse genetics has mainly relied on injection of 
antisense oligonucleotides into the yolk or cytoplasm of a fertilized oocyte. Morpholino oligonucleotides 
are DNA analogues modified to resist endogenous enzymatic degradation processes and are designed 
to be complementary to the 5’UTR of a specific gene to block translation (Summerton and Weller 
1997). Antisense morpholino oligonucleotide-mediated knockdown has been shown to phenocopy 
known zebrafish mutants (Nasevicius and Ekker 2000). While this approach has been successfully 
adopted to study gene function in a variety of model systems, prevalent limitations include dilution of 
efficiency through cell divisions, non-specific side effects and false-positive phenotypes through off-
target knockdowns (Heasman 2002). 
1.6.2.3 Targeted genome editing
Elucidating gene function by altering the coding sequence of a specific gene first and investigating 
the resulting phenotype later depends on the availability of efficient and sequence-specific methods 
for targeted genome editing in the model system of choice. Genome editing comprises a variety of 
applications, such as base pair deletions to induce frame shifts, substitutions to alter the amino acid 
sequence and therefore the protein structure, or insertion of exogenous DNA fragments into the host 
genome. 
Recombination between homologous sequences permits the introduction of any desired fragment 
from exogenous DNA plasmid into the target genome. HR provides an unmatched precision (e.g. 
single nucleotide modifications) in the field of genome engineering. First established in yeast, HR has 
become the conventional method for mouse geneticist, aided by the existence of mouse ESCs, to 
engineer the mouse genome (Hinnen et al. 1978; Orr-Weaver et al. 1981; Thomas et al. 1986; Thomas 
and Capecchi 1987), in particular to investigate the role of genes in development and disease. The 
dominant role of model organisms with experimentally manipulable genomes is reflected by the vast 
knowledge we obtained from reverse genetic applications about gene function fundamental biological 
process, which to contributed to the desire for the availably of genome editing methods as precise and 
efficient in other species.
Technologies developed for targeted mutagenesis such as zinc-finger nucleases (ZFNs), transcription 
activator-like effector nucleases (TALENs), and more recently RNA-guided systems can introduce 
chromosomal double-strand breaks (DSBs) to trigger endogenous repair pathways (Kim et al. 1996; 
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Lu et al. 2011; Tesson et al. 2011; Jiang et al. 2013; Wang et al. 2013). The error-prone repair of DNA 
DSBs by NHEJ can produce specific gene lesions but comes at the cost of unpredictable insertion and 
deletion mutations. Homology directed repair comes with the advantage of having complete control 
over the genomic modifications. By presenting donor DNA with homologous sequences to the desired 
locus, base pair deletions, insertions and substitutions of choice can be produced, extending the list of 
experimental applications beyond the generation of mutagenic lesions in coding sequences. 
1.6.2.4 Zinc-finger nucleases
The ability to do reverse genetics - manipulate any desired locus in the genome followed by investigation 
for the phenotypic consequences - has been significantly enhanced by the emergence ZFNs. These 
hybrids comprised of zinc-finger arrays and FokI endonuclease offer precise genetic modification, in 
particular in living organisms that previously proofed too complicated or impossible to experimentally 
manipulate, for instance flies, fish or rats (Bibikova et al. 2002; Doyon et al. 2008; Meng et al. 2008; 
Geurts et al. 2009). The applications for ZFNs go beyond determining the biological role of arbitrary 
genes during development. ZFN-mediated disruption of HIV host co-receptor chemokine receptor 
5 in T cells has been demonstrated to provide heritable protection against HIV-1 infection in vivo, 
highlighting the potential of ZFNs for therapeutic purposes (Perez et al. 2008). Similarly, the mutated 
alleles causing monogenic disorders could be specifically targeted and restored in their wild-type form. 
Cys2His2 zinc-fingers are DNA-binding domains that typically recognize three base pairs of DNA 
and are assembled in arrays of three to six fingers, therefore providing sequence specificity through 
binding to 18-36 base pairs of genomic DNA (Urnov et al. 2010). The zinc-finger arrays are fused to 
the non-specific proteolytic domain of the FokI (Flavobacterium okeanokoites) endonuclease. FokI 
nucleases catalyze DNA cleavage as dimers, thus the assembly of two customized ZFNs for one 
target locus is prerequisite for the generation of a DSB (Bitinaite et al. 1998). Development of obligate 
heterodimeric FokI nuclease domains has improved target specificity through reduced occurrence of 
unwanted homodimers (Miller et al. 2007). Following the generation of a ZFN-mediated site-specific 
DSB, NHEJ is triggered. Erroneous repair - insertion or deletion of base pairs - is likely to induce 
heritable frameshift mutations. 
1.6.2.5 Transcription activator-like effector nuclease
Part of the desire for an alternative method stems from the difficult assembly process of individual 
zing-fingers, which has been reported as inefficient and laborious (Ramirez et al. 2008). TALENs are 
similar to ZFNs, as both are chimeras consisting of a customizable DNA-binding domain and a non-
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specific FokI cleavage domain. The DNA-binding domain in TALENs is an array of highly conserved 
repeats, so-called TAL effectors, which were discovered in plant pathogenic bacteria. Upon entering 
the host plant cell, these transcriptional regulators are able to directly bind genomic DNA, therefore 
alter gene transcription in the nucleus during the course of pathogenesis (Boch and Bonas 2010). 
Binding specificity is achieved through tandem repeats in the central DNA-binding domain. Each 
repeat consists of two hyper-variable amino acid residues and allows binding to one base pair of 
genomic DNA (Boch et al. 2009; Moscou and Bogdanove 2009). The modularity of TAL effectors allows 
the construction of artificial effectors with novel binding specificities to target essentially any sequence 
of interest. As with ZFNs, the ability of TALENs to alter gene expression has been tested in a wide 
range of model organisms and cell types (Joung and Sander 2012). Studies reporting modification of 
the zebrafish genome were the first instances of gene disruptions created by TALENs in a vertebrate 
system (Huang et al. 2011; Sander et al. 2011). In addition, TALEN-mediated DSBs complemented 
with single-stranded DNA oligonucleotide donors yielded precise insertions into the zebrafish genome 
(Bedell et al. 2012). In this instance a loxP-site was inserted, offering the possibility to elucidate gene 
function in conditional mutants based on the Cre/lox or Flp/FRT recombination system (Branda and 
Dymecki 2004). In medaka, the successful generation of heritable lesions via TALENs has been 
reported; an exon of DJ-1, a gene implicated in the onset of early Parkinson’s disease, has been 
targeted (Ansai et al. 2013). Both TALENs and ZFNs have been used to specifically activate gene 
expression, adding targeted transcriptional gene regulation to the list of applications. Instead of the 
FokI proteolytic fragment, a transcriptional activator domain was fused to the DNA-binding domain 
(Blancafort et al. 2004; Cermak et al. 2011; Miller et al. 2011), making them highly versatile tools to 
modify genes and gene expression. 
1.6.2.6 RNA-guided genome modification
With more and more genomic resources available, there is an increasing demand for reliable reverse 
genetic approaches in fish. The rise of TALENs can be attributed to their easy design and rapid modular 
assembly; each TAL effector repeat recognizes one base pair in the target-binding site. A more recent 
class of engineered endonucleases employed for genome editing purposes achieves sequence 
specificity independent of a DNA-binding domain. RNA-guided nucleases are part of the adaptive 
immune system in bacteria and archea, which protects the organism against invading foreign DNA 
(Horvath and Barrangou 2010; Marraffini and Sontheimer 2010). Short fragments of nucleic acids from 
previous viral infections are integrated as clustered, regularly interspaced, short palindromic repeats 
(CRISPRs) into the host genome. Upon renewed infection, short CRISPR-derived RNAs (crRNAs) are 
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transcribed and guide the CRISPR-associated (Cas) protein, a non-sequence-specific nuclease, to the 
foreign genetic material, which will then be cleaved and inactivated. In type II CRISPR/Cas systems, 
another type RNA, trans-acting antisense RNA (tracrRNA), forms an RNA duplex together with pre-
crRNA that is processed by RNase III (Deltcheva et al. 2011). The CRISPR/Cas system modified for 
genome editing purposes in eukaryotic cells features a single guide RNA (sgRNA), a hybrid between 
crRNA and tracrRNA, with 20 nucleotides of homology to the target. Immediately downstream follows 
the protospacer adjacent motif (PAM). The Streptococcus pyogenes Cas9 nuclease, which has been 
proposed to prefer the PAM sequence NGG, forms a ribonucleoprotein complex with the sgRNA and 
the homologous genomic target sequence. Choosing targets with deviations in the second or third 
nucleotide of the PAM sequence is detrimental to the cleavage efficiency, but does not entirely abolish 
cutting (Hsu et al. 2013; Jiang et al. 2013; Pattanayak et al. 2013). The binding specificity of the 
complex is determined by the sgRNA; therefore, the CRISPR/Cas approach requires generation of 
sgRNA matching the desired locus but is free of time-consuming engineering of specific DNA-binding 
fragments. The Cas nuclease and one specific guide RNA are the only components necessary and 
sufficient for induction of targeted DSBs. The efficacy of CRISPR/Cas system has been tested in 
human cells, zebrafish and mice (Chang et al. 2013; Cong et al. 2013; Hwang et al. 2013; Jao et al. 
2013; Mali et al. 2013b; Shen et al. 2013). The applications in zebrafish include recapitulation of known 
phenotypes (Chang et al. 2013), germline transmission of the induced mutagenic lesions (Hwang et 
al. 2013; Jao et al. 2013), recessive null-like phenotypes induced by biallelic gene disruption (Jao et 
al. 2013), and knock-ins of experimenter-provided donor oligonucelotides (Chang et al. 2013; Hwang 
et al. 2013). Furthermore, a nuclease-inactivated version of the Cas9 protein has been fused to a 
transcriptional activator, allowing RNA-guided gene regulation (Mali et al. 2013a). Up to five genomic 
loci have been targeted simultaneously in ESCs and (Jao et al. 2013; Wang et al. 2013). The possibility 
of multiplex gene targeting will be beneficial in a number of applications, for instance the simultaneous 
introduction of multiple recombination sites to create conditional mutant alleles in a single step. 
Particularly research involving teleost fish, where multiple paralogs of one gene can exist as a result 
of whole genome duplication events, will profit from the multiplex feature of the CRISPR/Cas system. 
Paralogous genes can be targeted simultaneously with a single injection into fertilized eggs at one-cell 
stage, instead of performing tedious sequential single-knockouts.
So far, RNA-guided nucleases proofed to be at least as effective and versatile as ZFNs or TALENs in 
generating DSBs, which are the substrates for both mutagenic and homology directed repair. However, 
one constrain, when using the Cas9 protein, is presented by the required presence of the PAM site 
in the target sequence. Additionally, studies systematically testing the impact of mismatches in the 
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guide RNA found that single mismatches, particularly the ones near the PAM, reduced cleavage 
activity. Multiple mismatches rendered the targeted cleavage even less effective (Hsu et al. 2013). 
Furthermore, the system tolerated up to three mismatches, especially at PAM-distal positions of the 
sgRNA, highlighting the need for improved binding specificity in order to avoid off-target effects (Mali 
et al. 2013a).
1.7 Methodological approaches allowing the identification of upstream 
regulators of regulatory DNA elements
Chromatin immunoprecipitation offers the possibility to identify genomic DNA targets for a given 
TF in vivo. Interacting genomic DNA is identified by high-throughput sequencing following the co-
immunoprecipitation with the protein of interest using an antibody against the protein (Collas and 
Dahl 2008). Likewise, prior knowledge of the binding site composition recognized by a TF allows 
bioinformatics-based search in non-coding promoter and enhancer regions. Computationally identified 
putative genomic targets need to be experimentally validated. Although chromatin immunoprecipitation 
is a very elegant method to show direct protein-DNA interactions in vivo, it is not suited to systematically 
search for transcriptional regulators of a given regulatory DNA. This would require the availability of 
specific antibodies against each protein or transgenic lines expressing epitope-tagged TFs. 
Interactions between TFs and a defined promoter have been successfully tested in yeast-one-hybrid 
and luciferase reporter assays. In the yeast-one-hybrid system, the protein is fused to an artificial 
activation domain and upon binding to the regulatory DNA, reporter gene expression (e.g., histidine 
synthase) is activated (Li and Herskowitz 1993). Although this approach indicates physical protein-
DNA interactions, it is unable to reveal the regulatory mechanisms and the strength of interactions.
The luciferase assay-based trans-regulation screen (TRS) has been shown to overcome those 
limitations. In this approach, cultured cells are co-transfected with the regulatory element upstream 
of a luciferase reporter (e.g., firefly luciferase), an expression vector encoding the candidate gene 
and a second reporter (e.g., Renilla luciferase). The obtained relative luminescence signals provide 
knowledge about the relative strength of activation or repression.
Since the approach is cell culture-based and requires no tedious modifications of cDNA clones, rapid 
screening of transcriptome-scale cDNA libraries is possible, as successfully demonstrated for the 
regulatory element of the Atoh7 (also known as Ath5), a TF indispensable for ganglion cell specification 
(Souren et al. 2009).
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1.8 Aim of this thesis
Over the last decades teleosts have become an increasingly popular model to study key developmental 
events and to dissect basic biological processes (Furutani-Seiki and Wittbrodt 2004). In particular 
the teleost eye, which is constantly growing from a compartmentalized stem cell domain, constitutes 
an excellent system to explore post-embryonic neurogenesis and the coordinated growth of several 
connected tissues. A recent study provided compelling evidence for the existence of multipotent NSCs 
in the post-embryonic medaka retina (Centanin et al. 2011). However, the molecular mechanism and 
the transcriptional framework underlying stemness in adult NSCs remain poorly understood. 
This study aims to shed light on the gene regulatory framework orchestrating stem cell features in the 
retina by analyzing the regulatory cues controlling the expression of Rx2, a bona fide molecular marker 
for multipotent RSCs.
In addition, the study aims to establish the genetic tools to elucidate the role of Rx2. A plethora of 
studies in recent years described methods allowing the targeted modification of the genome (Gaj et al. 
2013). These methods opened the opportunity to take advantage of reverse genetics with a precision 
previously available in a limited selection of model organisms. In both medaka and zebrafish, TALENs 
have been demonstrated to successfully introduce heritable mutations into the genomic sequences 
of choice (Sander et al. 2011; Ansai et al. 2013). Taking advantage of specific TALENs targeting 
endogenous Rx2, loss-of-function mutants are established, which will be analyzed in the future.
   
   
  RESULTS
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2 Results
2.1 Identification of regulators of retinal stem cell features
2.1.1 Rx2 is specifically expressed in the eye
The embryonic expression of Rx2 was first observed at the late neurula stage (stage 18) in retinal 
progenitors following the completion of optic vesicle evagination (Figure 3A). Later (stage 24) it was 
uniformly expressed in all RPCs throughout the proliferating mono-layered optic cup (Figure 3B). Rx2 
was centrally down-regulated concomitant with the onset of differentiation from the center, where the 
first progenitors exit the cell cycle and differentiate terminally into distinct neural retinal cell types. 
During the ongoing retinogenesis Rx2 was progressively restricted to the margins of the expanding 
optic cup. 
Figure 3. Eye-specific TF Rx2 is expressed throughout eye development.
(A-C) Brightfield images of whole-mount preparations at various developmental stages. Rx2 transcripts are
strongly detected in the optic vesicle (stage 18, A), the optic cup (stage 24, B) and the eye (stage 34, C).
2.1.2 Rx2 is expressed in the peripheral-most part of the post-embryonic stem 
cell domain
Detailed analysis of the post-embryonic pattern of Rx2 mRNA or protein and comparison with transgenic 
reporter animals expressing fluorescent proteins under the control of the Rx2 CRE (Martinez-Morales 
et al. 2009; Inoue and Wittbrodt 2011) consistently revealed expression in stem cells in the most distal 
domain of the CMZ (stage 35) (Figure 4A’). The CMZ is populated by proliferating and undifferentiated 
cells, as indicated by the expression of the M-phase marker PHH3, the incorporation of the base 
analogue BrdU and the expression of the S-phase marker PCNA (Bravo et al. 1987; Negishi et 
al. 1991) (Figure 4B-D). Whereas PCNA protein co-localized with the majority of Rx2 protein and 
fluorescent reporter expression, PCNA staining was absent from the peripheral-most Rx2-positve cells 
(Figure 5F-J). Likewise, BrdU was incorporated only in the central-most Rx2-expressing cells after a 
short pulse (not shown). In contrast to the findings at post-embryonic stages, peripheral Rx2-positive 
Rx2
A B C
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cells continuously expressed PCNA during optic cup stages (Figure 5A-E). Expression of Rx2 and 
differentiation markers appeared mutually exclusive in the peripheral retina (Figure 4E). Rx2 protein 
was also detected in cells of the INL and photoreceptor cells in the ONL (Figure 4A’’). Immunostaining 
against glutamine synthetase confirmed that Rx2 reporter and protein co-localize in MGCs throughout 
the INL (Figure 6). WISH analysis of Rx2 expression was consistent with Rx2 immunostaining and 
reporter expression, confirming that the Rx2 reporter faithfully recapitulates Rx2 expression in the 
post-embryonic retina (Figure 3C).  
The expression analysis highlighted expression of Rx2 as a specific marker for the peripheral-most 
region in the CMZ and underscores the precise spatial reporter expression of the Rx2 CRE. 
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Figure 4. Rx2 reporter and protein expression co-localizes in the post-embryonic retina.
(A-E) Confocal stacks of frontal sections on the retina of transgenic Rx2 reporter (Rx2::Tub-GFP) embryo at 
stage 34. Transgenic reporter expression driven by Rx2 CRE (A, green) and Rx2 protein (A, red) closely overlap 
(A). Higher magnifications of boxed regions in (A) highlight overlapping expression in the peripheral CMZ (A’) and 
MGCs (white arrowheads) and photoreceptor cells (white arrow) of the central NR (A’’). Dashed lines demarcate 
border between CMZ and differentiated retina (A’) or between layers of the retina (A’’). Rx2 reporter expression in 
the periphery of the NR overlaps with mitotic markers BrdU (B, red), PCNA (C, red) and pHH3 (D, red). Markers 
of differentiated neurons Zpr1 (E, red) and Islet1 (E, red) are absent from the juvenile CMZ. Scale bars: 50 μm 
in A and B; 25 μm in A’ and A’’.
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Figure 5. Rx2 and PCNA proteins are co-expressed at embryonic and post-embryonic stages.
(A-E) Confocal stacks of transversal sections show co-expression of Rx2 and PCNA in the optic cup (stage 24). 
(F-J) Confocal stacks of transversal sections show expression of Rx2 and PCNA in the post-embryonic retina 
(stage 37). Higher magnification pictures of boxed regions (A and F) are shown in (B-E and G-J). Scale bars: 50 
μm in A and F; 10 μm in B and G.
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Figure 6. Rx2 labels MGCs in the central retina. 
(A-D) Confocal stacks of frontal sections on the retina of transgenic Rx2 reporter (Rx2::Tub-GFP) embryo at 
stage 34. Transgenic reporter expression driven by Rx2 CRE (B, green) and Rx2 protein (C, red) co-localizes in 
the INL with glutamine synthetase immunostaining (D, grey) in the INL. Scale bar: 10 μm.
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2.1.3 Identification of regulators of Rx2 expression
To identify genes controlling RSC-specific features, we investigated the regulatory input guiding Rx2 
expression. For the systematic survey for regulators upstream of Rx2 the trans-regulation screen was 
employed. This cell culture-based method involves the co-transfection of a reporter construct, which 
has the luciferase coding sequence downstream of the regulatory region of interest, together with 
candidate regulators. The luciferase reporter assays provide insight into the strength of the interaction 
and the actual regulatory function (e.g., activating) of the candidate protein. Rapid transfection under 
high-throughput conditions allows screening of large quantities of candidate genes in parallel on 
one or multiple regulatory regions. This approach reliably identified de novo upstream regulators of 
Atoh7 expression (Souren et al. 2009). We took advantage of the relatively short Rx2 CRE, which is 
sufficient to recapitulate the entire expression pattern of Rx2 in vivo as described above, and tested 
1151 individual full length cDNA clones representing a large complement of the putative medaka 
TF in a dual luciferase-based screen in cultured mammalian (BHK21) cells (Table 1). Activating or 
repressing candidates were validated by their expression relative to the expression of Rx2. Among the 
51 genes analyzed, Sox2 was the top activator expressed in the mature retina. Gli3 and Her9 were 
the regulators with the strongest repressive activities. Tlx, not present in the full-length TF library, was 
included because its particular expression in the CMZ and its role in NSCs (Yu et al. 1994; Monaghan 
et al. 1995; Shi et al. 2004). 
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Table 1. Candidate regulators of Rx2 identified in the TRS. 
Normalized ratios, Ensembl gene IDs and protein names are shown for the putative activators and repressors. 
Tested factors with normalized ratio of equal or more than 3.388 were considered as putative activators (left). 
Normalized ratios of equal or less 0.2755 were assigned as putative repressors (right). Factors are listed in 
descending order according to their normalized ratios. The TFs Sox2, Her9 and Gli3 (bold) were the strongest 
regulators expressed in the post-embryonic CMZ and therefore tested for the ability to regulated Rx2 in vivo.
2.1.4 Rx2, Sox2, Tlx, Her9 and Gli3 are co-expressed in the post-embryonic 
CMZ
To address the function of our candidate genes, we first examined the expression of Sox2, Tlx, Gli3 
and Her9 with respect to Rx2. Expression of the pan-neural determinant Sox2 was detected throughout 
the CMZ, from cells residing distally in the periphery, to more centrally located rapidly proliferating 
progenitors, to differentiating cells closest to the differentiated central retina (Figure 7A-C). Tlx and 
Her9, which were both expressed in the central CMZ, partially overlapped with the Rx2 expression 
domain (Figure 7D-I). Tlx- and Her9-positive cells that were Rx2-negative were found more centrally in 
Ratio Ensembl ID Protein name 
6.8223 ENSORLG00000013930 MAFB  (2 of 2) 
6.3932 ENSORLG00000011685 SOX2 
5.6326 ENSORLG00000009709  
5.0471 ENSORLG00000005001 SOX4 
4.8001 ENSORLG00000012110 SOX1 
4.3921 ENSORLG00000006390 P53_ORYLA 
4.3592 ENSORLG00000012314 RND1 
4.2939 ENSORLG00000017977  
4.2580 ENSORLG00000001780 Q9PT76_ORYLA 
4.2226 ENSORLG00000000325 TRIM24 
4.0101 ENSORLG00000014996 SOX11 
3.9707 ENSORLG00000014398 TBL1XR1 
3.8176 ENSORLG00000014335  
3.8015 ENSORLG00000007859  
3.7558 ENSORLG00000011491 MYCBP2 
3.6907 ENSORLG00000011362 DUSP4 
3.5596 ENSORLG00000014065  
3.5320 ENSORLG00000003250  
3.5207 ENSORLG00000007960  
3.5159 ENSORLG00000012362  
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3.388 were considered as putative activators (left). Normalized ratios of equal or less 
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order according to their normalized ratios. The TFs Sox2, Her9 and Gli3 (bold) were the 
strongest regulators expressed in the post-embryonic CMZ and therefore tested for the 
ability to regulated Rx2 in vivo. 
 
 
Ratio Ensembl ID Protein name 
0.2745 ENSORLG00000008319  
0.2724 ENSORLG00000010756 CYR61 
0.2673 ENSORLG00000014942  
0.2661 ENSORLG00000019628  
0.2638 ENSORLG00000007548 ACVRL1 
0.2633 ENSORLG00000013006  
0.2612 ENSORLG00000017539 CDK5 
0.2593 ENSORLG00000004561 DLX5 
0.2588 ENSORLG00000001137 MYST1 
0.2570 ENSORLG00000004126 ROBO4 (1 of 2) 
0.2508 ENSORLG00000003221 IFRD2 
0.2428 ENSORLG00000010055 Q7T1Q8_ORYLA 
0.2360 ENSORLG00000007641 Q9PT79_ORYLA 
0.2334 ENSORLG00000008072  
0.2333 ENSORLG00000015121 Q1XHL4_ORYLA 
0.2285 ENSORLG00000010717 PDCD2 
0.2259 ENSORLG00000013422 ARG1 
0.2247 ENSORLG00000009030 RAB6C 
0.2210 ENSORLG00000008054  
0.2156 ENSORLG00000003982 GADD45G (1 of 3) 
0.2035 ENSORLG00000017855 TBL1Y 
0.2010 ENSORLG00000014546 DLK1 
0.1989 ENSORLG00000013231 GADD45B (1 of 2) 
0.1981 ENSORLG00000004319 COL1A2 
0.1959 ENSORLG00000006591 IFT57 
0.1939 ENSORLG00000009381 CHUK  (2 of 2) 
0.1918 ENSORLG00000017412 PAX1 
0.1906 ENSORLG00000018979 STAU1 
0.1752 ENSORLG00000004166  
0.1666 ENSORLG00000005453 HER9 
0.1031 ENSORLG00000012490 GLI3 
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the CMZ, where cells express PCNA and rapidly incorporate BrdU. In contrast, highest levels of Gli3 
transcripts were found in the peripheral RPE surrounding the CMZ, while lower levels of Gli3 were 
also observed in the peripheral post-embryonic CMZ (Figure 7J-L). Two-color WISH confirmed the 
presence of Gli3 transcripts in the peripheral-most Rx2-expressing cells inside the CMZ (arrowhead 
in Figure 7L). 
Taken together the expression of all Rx2 candidate regulators is tightly associated with the expression 
of Rx2 in distinctive domains of the post-embryonic retina and where they partially overlap with Rx2 in 
the CMZ. 
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Figure 7. Spatial expression pattern of Rx2 regulators in the post-embryonic retina of medaka.
(A-L) Confocal stacks of whole-mount two-color fluorescence in situ hybridizations with probes against Sox2 (B, 
red), Tlx (E, red), Her9 (H, red), Gli3 (K, red) and Rx2 (A, D, G, J, green) on stage 35 embryos. Rx2 (A, D, G, J, 
green) transcripts are found in the CMZ, INL and ONL. Sox2 (B, red) is expressed throughout the CMZ. Tlx (E, 
green), Her9 (H, green) have similar expression patterns in the central CMZ at stage 35, overlapping partially 
with Rx2 expression. Gli3 mRNA (K, red) is expressed primarily in the pigmented epithelium adjacent to the CMZ 
(inset in L). Gli3 mRNA in the CMZ is present in the peripheral-most Rx2-expressing cells (white arrowhead). 
Dashed line demarcates boundary between RPE and CMZ. Scale bar: 50 μm.
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2.1.5 The Sox2, Tlx and Her9 cis-regulatory elements recapitulate endogenous 
gene expression
To analyze the expression of Sox2, Tlx and Her9 in the CMZ in more detail, transgenic reporter lines 
were generated. Based on the conservation in comparison to orthologous sequences, non-coding 
genomic fragments were tested for their cis-regulatory activity in the post-embryonic medaka retina 
(Ramialison et al. 2012). Reporter expression driven by the 2.4 kb fragment identified upstream of 
Sox2 was located in the entire CMZ (Figure 8A-D). The expression clearly overlapped with staining 
for Rx2 in the periphery and was extended into the central domain of the CMZ. Consistent with the 
expression analysis for the transcripts of Tlx and Her9, the respective transgenic reporter lines were 
expressed in the CMZ. Expression of both transgenic reporters was detected in the central-most Rx2 
domain. Similar to Sox2, both Tlx (Figure 8E-H) and Her9 (Figure 8I-L) reporter activity appeared also 
in Rx2-negative cells of the central CMZ. In contrast, neither Tlx::GFP nor the Her9::GFP transgenic 
fish did express GFP in the most distal Rx2-positive cells. 
To put these findings into relation, the transgenic Atoh7 reporter, labeling the central-most CMZ (Del 
Bene et al. 2007), was added (Figure 9). Transgenic fish carrying three reporter transgenes were 
analyzed for the expression of nuclear monomeric RFP (Rx2), cytoplasmatic GFP (Tlx) and membrane-
bound YFP (Atoh7). Cross sections through the eye of hatchlings revealed three distinct domains: 
Consistent with previous findings, the cells in the most distal domain expressed the Rx2 reporter only 
(1). The next domain, which is located more centrally, was occupied by cells labeled with Rx2 and Tlx, 
but not by Atoh7 (2). The third domain, which did not express the Rx2 reporter, was entirely populated 
by memYFP-positive cells due to activity of the Atoh7 reporter transgene (3). At the transition from the 
second to the third domain Tlx was still expressed but did not spread as close as Atoh7 towards post-
mitotic neurons. 
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M N OFigure 8. Transgenic reporters for Sox2, Tlx and Her9 are expressed in the CMZ.
Confocal stacks of frontal sections on the retina of transgenic hatchlings. Peripheral CMZ is to the left, central 
retina is to the right.
(A-L) Expression of transgenic Sox2 (B), Tlx (F) and Her9 (J) reporter overlaps in part with Rx2 protein (C, G, K) 
in the CMZ. Scale bar: 50 μm.
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Figure 9. Transgenic Rx2, Tlx and Atoh7 reporter lines label different domains in the post-embryonic 
CMZ.
(A) Confocal stacks of frontal sections on the retina of a triple-transgenic (Rx2::H2B-mRFP, Tlx::GFP and 
Atoh7::memYFP) hatchling. Higher magnifications of boxed region in (A) highlight the partially overlapping 
expression in the CMZ of all three reporter lines. Rx2::H2B-mRFP occupies the peripheral-most CMZ (1) and 
overlaps in part with Tlx::GFP (2). Tlx reporter expression extends into the most central part of the CMZ, labeled 
by Atoh7::memYFP (3). Rx2::H2B-mRFP at this stage does not overlap with the Atoh7::memYFP. Dashed 
(yellow) lines demarcate borders between peripheral and central-most Tlx reporter expression domain. Scale 
bars: 50 μm.
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2.1.6 Conditional clonal analysis in the post-embryonic medaka retina
Since the in vitro characterization and the overlapping expression pattern of Sox2 and Tlx with Rx2 
consistently argued for an activating function of Sox2 and Tlx, their interaction was addressed by a 
clonal gain-of-function approach in the post-embryonic retina.
For this, we employed a conditional, steroid-inducible expression system, which provided spatio-
temporal control over the expression of the gene of interest (Emelyanov and Parinov 2008) and tested 
the consequences of acute clonal activation of Sox2 (cska::LexPR LexOP::Sox2) and Tlx (cska::LexPR 
LexOP::Tlx) gain-of-function through DNA microinjection into fertilized oocytes (Figure 10A). Positive 
clones were labeled by the expression of fluorescent proteins (LexOP::H2A-Cherry or LexOP::Cherry), 
encoded by co-injected reporter plasmids. Injection of the plasmids into a single cell at two-cell-stage 
in combination with the ubiquitous cska promoter (Grabher et al. 2003) facilitated randomized mosaic 
expression throughout all three nuclear layers. Expression of the candidate factors was hormonally 
induced (4 dpf) when the majority of cells in the central retina had exited the cell cycle and already 
differentiated into the neuronal and glial cell types (Figure 10B). Transgenic Rx2::Tub-GFP embryos, 
having reporter expression controlled by the same Rx2 CRE used in the TRS, were used as a sensitive 
read-out in vivo (Figure 10C). 
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Figure 10. Clonal gain-of-function in the central retina.
(A) Scheme outlining functional assays for clonal expression Rx2 activators. Driver (cska::LexPR LexOP::Sox2; 
cska::LexPR LexOP::Tlx) and effector (LexOP::Cherry) plasmids are co-injected into transgenic Rx2 reporter 
embryos (Rx2::Tub-GFP). Treatment with mifepristone results in mosaic expression pattern in the retinae of the 
embryos. Schematic cross section of the differentiated medaka retina with Rx2::Tub-GFP expression (green) in 
the CMZ, INL and ONL. Gain-of-function clones are randomly introduced into the central retina and identified 
via the co-expressed fluorescent protein (red) and examined for Rx2 CRE trans-activation (clones that are both 
green and red).
(B) Experimental timeline of clonal gain-of-function assay.
(C) Transgenic Rx2::Tub-GFP embryo after injection with control plasmids (cska::LexPR and LexOP::Cherry) 
and subsequent mifepristone treatment as outlined above. Anterior is up, posterior is down. Mosaic cherry 
expression is spread randomly throughout the head and eyes, while Tub-GFP expression continues unperturbed 
in the retina.
2.1.7 Sox2 and Tlx activate Rx2 expression in vivo
Sections of transgenic embryos at 7 dpf showed that the combined expression of Sox2 and Tlx resulted 
in strong Rx2 reporter activation (40/48, 83.33%) in all three nuclear layers (Figure 11). In addition to 
reporter expression outside of the Rx2 expression domain, enhanced levels of Rx2 were observed 
indicated by the Rx2 reporter (Rx2::Tub-GFP) in MGCs and photoreceptor cells, which co-expressed 
Sox2 and Tlx.  
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Figure 11. Co-expression of Sox2 and Tlx trans-actives the Rx2 reporter in the central retina.
(A-D) Confocal stacks of frontal sections on the central retina of transgenic fish (Rx2::Tub-GFP) at 7 dpf. Cells 
in all three nuclear layers of the NR (GCL, INL and ONL) over-expressing Sox2 and Tlx together (C, red), show 
ectopic Rx2 reporter activity (B, green). White arrowheads point to representative co-localizing cells. Scale bar: 
10 μm.
2.1.8 Sox2 and Tlx individually activate Rx2 expression in vivo
Similarly, clonal miss-expression of Sox2 (32/48, 66.67%; Figure 12A-D) or Tlx (142/173, 82.08%; 
Figure 12F-I) individually resulted in ectopic Rx2 reporter activation. To corroborate that Sox2 and Tlx 
activate the endogenous Rx2 expression in vivo, WISH and immunohistochemistry were combined in 
whole-mount preparations (stage 30). DNA microinjection into two-cell stage wild-type embryos created 
mosaic expression in the central retina. Clones expressing Sox2 (53/62, 85.48%; Figure 12E-E’’’) or 
Tlx, (34/56, 60.71%; Figure 12J-J’’’), co-expressed ectopic Rx2 mRNA, which was never detected in 
controls (co-injection of cska::LexPR LexOP and LexOP::H2B-EGFP). These results revealed that 
Sox2 or Tlx trans-activate the endogenous Rx2 promoter as well as the Rx2 reporter in vivo and thus 
trigger Rx2 expression in differentiated cells of all three nuclear layers.
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Figure 12. Sox2 or Tlx gain-of-function clones activate Rx2 reporter expression and ectopic Rx2 
expression in the central retina.
(A-D) Confocal stacks of frontal sections showing the central retina of Rx2::Tub-GFP embryo 7 dpf. Cells in the 
GCL and INL expressing Sox2 (C, red) show ectopic Rx2 reporter activity (B, green).
(E-E’’’) Confocal stacks of whole-mount embryo show co-localization of Sox2 (E’’’, false-colored red) and Rx2 
mRNA (E’’, false-colored green) in the central retina at stage 30 (E).
(F-I) Confocal stacks of frontal sections showing the central retina of Rx2::Tub-GFP embryo 7 dpf. Cells in the 
ONL expressing Tlx (H, red) show ectopic Rx2 reporter activity in the INL and increased activity in the ONL (G, 
green). Tlx-positive clones of the ONL exhibit modified cell morphology in comparison with wild-type cells (inset 
in F).
(J-J’’’) Confocal stacks of whole-mount embryo show co-localization of Tlx (J’’’, false-colored red) and Rx2 mRNA 
(J’’, false-colored green) in the central retina at stage 30 (J). Scale bars: 10 μm in A, E’, F and J’; 50 μm in E and 
J.
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2.1.9 Clonal analysis reveals promotion of RSC-specific features by Sox2 and 
Tlx in vivo
The rationale behind investigating the regulation of Rx2 was the possibility to identify transcriptional 
RSC modulators. Given that Sox2 and Tlx are activators of Rx2 in vivo, we addressed whether clonal 
activation of Rx2 expression by Sox2 and Tlx coincided with the induction of other RSC features. In 
response to ectopic Sox2 or Tlx expression, changes in cell shape were observed, for instance in 
photoreceptors lacking the characteristic cone- or rod-like shape (inset in Figure 12F). To evaluate 
whether clonal activation of Rx2 expression by Sox2 or Tlx coincided with the induction of other RSC 
features, we first examined the mitotic state in those cells. Gain-of-function clones were induced as 
described above and analyzed for the expression of PCNA. In sections of the central retina of controls 
analyzed at 7 dpf, PCNA-positive clones were never detected. In contrast, both, the expression of 
Sox2 (7/11, 63.63%; Figure 13A-E) as well as Tlx (3/23, 13.04%; Figure 13F-J) resulted in enhanced 
mitotic activity as indicated by PCNA staining. This shows that clonal ectopic expression of Sox2 or 
Tlx re-activated the proliferative potential and shifted cells back into the mitotically active state. PCNA-
positive clones were observed in the INL and ONL, indicating that de-differentiation was widespread 
and not restricted to one particular type of retinal neurons. 
Figure 13. Expression of Sox2 or Tlx promotes stem cell features in terminally differentiated neurons.
(A-J) Confocal stacks of frontal sections showing the central retina of transgenic Rx2::Tub-GFP embryo 7 dpf. 
Sox2 (D, red) activates Rx2 reporter expression (C, green) and coincides with PCNA staining (B, grey) in the 
ONL. Sox2-positive cell of the ONL shows modified cell morphology in comparison with adjacent wild-type cells 
(E, blue). Likewise, a proportion of Tlx-expressing neurons (I, red), which activate the Rx2 promoter (H, green), 
co-localize with staining for PCNA (G, grey). Scale bar: 10 μm.
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2.1.10 Transient exposure to Tlx transforms neurons into label- retaining cells
Label-retention over extended periods of time has been shown to be a common feature of bona fide 
stem cells in different animal niches (Bickenbach 1981; Tumbar et al. 2004). The tools for conditional 
gene expression described earlier allowed us to transiently mis-express Rx2 activators and fluorescent 
proteins in the same cells in vivo. To address the label-retaining potential in cells expressing Rx2 in 
response to the clonal activation of Tlx, the retention of fluorescent protein 49 days after the transient 
induction of Tlx was analyzed. The clonal expression of Tlx was repeated as described above in 
Rx2::Tub-GFP transgenic embryos. Limited expression of Tlx was activated by a hormone pulse (d4-
d7) and the fish were allowed to grow for 7 additional weeks in the absence of the inducing hormone 
(Figure 14A). Strikingly, 49 days after end of the transient induction fluorescently labeled cells were 
still observed. Those cells were positive for ectopic GFP and cherry (Figure 14B-E). Overlap of the 
green and red fluorescence in the central retina indicated that transient activation of the Rx2 CRE 
was successful at 7 dpf and that these cells retained both labels for almost 50 days. Control retinae, 
where cherry expression was induced in parallel, did not retain any ectopic label in the central retina. 
Taken together, this analysis highlighted the potential of Sox2 and Tlx to trigger stem cell features in 
differentiated retinal cells, which are highly reminiscent of RSCs.
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Figure 14. Expression of Tlx promotes label retention in terminally differentiated neurons.
(A) Experimental timeline of short-term clonal over-expression followed by long-term chase. 
(B-E) Confocal stacks of frontal sections showing the central retina of transgenic Rx2::Tub-GFP fish 56 dpf. 49 
days after end of mifepristone treatment, which induced clonal trans-activation of the Rx2 reporter through Tlx, 
cells still retain red (C, red) and green fluorescent proteins (D, green). White arrowheads point to representative 
co-localizing cells. Scale bar: 10 μm.
2.1.11 Gli3 and Her9 repress Rx2 in the CMZ
To assess whether Gli3 and Her9 act as transcriptional repressors of Rx2 in vivo, their clonal expression 
in cells endogenously expressing Rx2 was triggered. As described above, Rx2-positive cells resided 
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in the peripheral CMZ, centrally and peripherally flanked by the Her9 and Gli3 expression domains 
respectively (Figure 15B). Gli3 transcripts were primarily detected distantly in the adjacent RPE. Her9 
mRNA conversely was found in the centrally adjacent CMZ. Therefore the Gli3 and Her9 expression 
was shifted into the Rx2 domain using inducible clonal expression in transgenic fish (Figure 15C-D). 
The clones were traced via a co-expressed nuclear GFP (H2B-EGFP) (Figure 15A). An Rx2 antibody 
was employed to assess Rx2 protein presence and levels. Clonally increased Gli3 expression in the 
peripheral CMZ (Rx2::LexPR LexOP::Gli3 LexOP::H2B-EGFP), resulted in the loss of Rx2 protein in 
almost 40% of the ectopic Gli3-positive cells (13/33, 39.39%; Figure 16E-H). Of the clones expressing 
ectopic Her9 within the Rx2 domain (Rx2::LexPR LexOP::Her9 LexOP::H2B-EGFP), 20% showed 
decreased levels of Rx2 protein (7/35, 20.00%; Figure 16I-L). In contrast, Rx2 protein expression 
remained unaffected (1/34, 2.94%; Figure 16A-D) in the control (Rx2::LexPR LexOP::Her9 LexOP::H2B-
EGFP). These findings are consistent with hypothesis that the domain of Rx2-positive stem cells is 
established and maintained by the activity of Sox2 and Tlx, is centrally (NR) and peripherally (RPE) 
confined by the expression of Her9 and Gli3.
Figure 15. Conditional clonal gain of Gli3 and Her9 in the CMZ. 
(A) Schematic cross section of the mature retina upon induction of clonal expression as indicated by H2B-EGFP 
under the Rx2 CRE. 
(B-D) Close up of the post-embryonic CMZ outlines the expression domains of RSC-marker Rx2, Gli3 and Her9 
(B) in the controls, upon increased Gli3 (C) or Her9 (D) expression in the peripheral Rx2 domain.
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Figure 16. Clonal over-expression of Gli3 or Her9 in the CMZ reduces Rx2 protein levels.
(A-L) Confocal stacks of transversal sections on transgenic retinae (Rx2::LexPR LexOP LexOP::H2B-
EGFP; Rx2::LexPR LexOP::Gli3 LexOP::H2B-EGFP; Rx2::LexPR LexOP::Her9 LexOP::H2B-EGFP) with 
immunostaining against the Rx2 protein at 9 dpf. 
(A-D) In control experiments (Rx2::LexPR LexOP LexOP::H2B-EGFP), Rx2 is detected in the peripheral-most 
cells of the CMZ (B, red) despite sustained expression of H2B-EGFP (C, green).
(E-H) Clonal expansion of the Gli3 (G, green) expression domain in the CMZ reduces levels of Rx2 protein (F, 
red) in transgenic fish (Rx2::LexPR LexOP::Gli3 LexOP::H2B-EGFP).
(I-L) Similarly, sections on transgenic fish (Rx2::LexPR LexOP::Her9 LexOP::H2B-EGFP) reveal reduction or 
loss of Rx2 staining (J, red) in the peripheral CMZ is observed in clones expressing Her9 (K, green). Dashed lines 
demarcate Rx2 domain in the CMZ. Dotted lines highlight affected clones. Scale bar: 10 μm.
2.1.12 Sustained expression of Gli3 and Her9 represses proliferation in the CMZ
Having shown that Rx2 activators Sox2 and Tlx promote RSC-specific behavior, we asked whether 
expression of Rx2 repressors mediates the opposite phenotype. To test this hypothesis the mitotic 
activity of clones expressing Gli3 or Her9 was investigated through PCNA immunostaining. Gain-of-
function clones were generated and traced as described above (Figure 15). In sectioned control retinae 
of embryos at 9 dpf, homogenous presence of PCNA protein was detected throughout the central 
domain of the CMZ, unaffected by expression of H2B-EGFP (3/38, 7.89%; Figure 17A-D). In contrast, 
in Gli3 gain-of-function clones PCNA was markedly reduced. Less or no PCNA protein was found in 
more than 36% of the H2B-EGFP-positive (indicative of Gli3 expression) cells (39/106, 36.79%; Figure 
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17E-H). Similarly, PCNA staining was strongly reduced or completely absent in more than 30% of the 
Her9 over-expressing cells (21/64, 32.81%), indicating that entry of RPCs or RSCs cells into S-phase 
of the cell cycle was prevented (Figure 17I-L). Taken together these results indicate that ectopic Gli3 
and Her9 expression in the CMZ antagonize both, Rx2 expression and proliferation in adult RSCs.  
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Figure 17. Clonal over-expression of Gli3 or Her9 in the CMZ reduces proliferation.
(A-L) Confocal stacks of transversal sections on transgenic retinae (Rx2::LexPR LexOP LexOP::H2B-
EGFP; Rx2::LexPR LexOP::Gli3 LexOP::H2B-EGFP; Rx2::LexPR LexOP::Her9 LexOP::H2B-EGFP) with 
immunostaining against the PCNA protein at 9 dpf. 
(A-D) PCNA labels a continuous group of mitotically active, undifferentiated cells in the CMZ (B, red).
(E-H) Gli3 gain-of-function clones (G, green) show frequently lowered PCNA staining (F, red) compared to control 
cells.
(I-L) Her9 gain-of-function clones (K, green) have less PCNA protein (J, red). Dotted lines highlight affected 
clones. Scale bar: 10 μm.
2.1.13 Sox- and Gli-binding sites are necessary for the functionality of the Rx2 
CRE 
To further address the significance of the identified trans-regulators for the accurate expression of Rx2, 
we analyzed the architecture of the Rx2 CRE. Applying evolutionary footprinting to uncover putatively 
functional, non-coding DNA elements by their conservation, binding sites for Sox, the strongest activator 
in the in vitro assay, as well as for Gli, the strongest repressor were identified. Alignment of non-coding 
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genomic DNA sequences upstream of the Rx2 transcriptional start site showed conservation between 
teleost fish species (Figure 18A). Despite low overall similarities of the entire medaka CRE to higher 
vertebrates, a conserved putative Sox-binding site was identified (Figure 18B). 
A
Sox Gli
B
Figure 18. The Rx2 CRE contains conserved Sox- and Gli-binding sites.
(A-B) Result of BLAT search for the 2.4kb medaka Rx2 CRE using the UCSC Genome Browser (1 in A). The 
region (2 in A), which contains the putative Sox-binding site (orange) and Gli-binding site (green) is conserved 
(B). Blue peaks indicate conservation of coding and non-coding DNA sequences among teleost species. 
The importance of conserved transcription factor binding sites (TFBSs) for the precise spatio-temporal 
expression coordinated by the Xenopus Rx CRE has been implicated previously (Danno et al. 2008; 
Martinez-De Luna et al. 2010). Given that the TF Sox2 is able to trans-activate expression of genes 
downstream of the medaka Rx2 CRE in vivo, we addressed whether alterations in the putative Sox-
binding site affect Rx2 reporter expression. To address this, two point mutations (Danno et al. 2008) 
were introduced into the core of the predicted Sox-binding site (Rx2::H2B-mRFP mtSox2) and the 
activity of the mutated Rx2 CRE in transgenic medaka embryos was tested. As described above, Rx2 
reporter activity accurately matched the expression of the Rx2 protein in the retina (Figure 19A-B). In 
contrast, mutations in the Sox TFBS resulted in an altered expression pattern.  In sectioned retinae of 
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stage matched transgenic Rx2::H2B-mRFP mtSox2 embryos, reporter activity in the CMZ was strongly 
reduced (Figure 19C-C’’’’). Also in the INL, where Rx2 is expressed in MGCs 9 dpf (Figure S2), the 
number of mRFP-positive cells was reduced (Figure 19D-D’’’). Interestingly, Rx2 reporter expression 
in photoreceptor cells of the ONL, where Sox2 is not expressed, was unchanged and identical to the 
control (Figure 19D-D’’’). Strikingly, the mutation in the putative Sox-binding site in the Rx2 CRE affects 
all domains of Rx2 expression that overlap with the expression of Sox2. The finding that upon mutation 
of the predicted Sox TFBS expression in the CMZ is strongly reduced, albeit not entirely abolished, 
highlights the in vivo relevance of the Sox-binding site contained within the Rx2 CRE for the activation 
of Rx2 expression in the peripheral CMZ. 
Figure 19. Mutation of Sox-binding site abolishes Rx2 cis-regulatory activity in the CMZ.
(A-B’’’) Confocal stacks of frontal sections on the retina of Rx2::H2B-mRFP transgenic embryo 9 dpf. Transgene 
expression (A, red), driven by Rx2 CRE, co-localizes with Rx2 protein in the CMZ, INL and ONL (A, green). 
Higher magnification pictures of boxed regions (A) are shown in (A’-A’’’’; B-B’’’).
(C-D’’’) Confocal stacks of frontal sections on the retina of Rx2::H2B-mRFP mtSox2 transgenic embryo 9 dpf. 
Number of cells with transgene expression (C, red), driven by mutated Rx2 CRE, is markedly reduced in the CMZ 
and INL in comparison to Rx2 immunostaining (C, green) and control transgene expression (A, red). In contrast, 
transgene expression in Rx2::H2B-mRFP mtSox2  fish continues in the photoreceptor cells of the ONL. Higher 
magnification pictures of boxed regions (C) are shown in (C’-C’’’’; D-D’’’). Dashed line indicates transition from 
CMZ to CR. Dotted line represents border between layers of the NR. Scale bars: 50 μm in A and C; 25 μm in A’ 
and C’.
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Given the ability of Gli3 to repress Rx2 in vivo, it was also investigated whether Gli TFs (like Sox) 
act as direct transcriptional regulators of the Rx2 CRE. Following the identification of a putative Gli 
TFBS (Sasaki et al. 1997), 11 bp containing the Gli DNA motif were deleted from the Rx2 CRE (Figure 
18B). Analysis of transgenic medaka fish (Rx2::H2B-mRFP delGli) revealed a marked shift in reporter 
expression from the peripheral CMZ to the mono-layered RPE (Figure 20B-B’’’). Consistent with our 
previous results from the Gli3 expression analysis, reporter expression within the RPE was detected 
only in epithelial cells adjacent to the CMZ in transgenic embryos (Rx2::H2B-mRFP delGli). mRFP 
expression in the transgenic control (Rx2::H2B-mRFP) was confined to the NR and absent from the 
RPE (Figure 20A-A’’’). Interestingly, in Rx2::H2B-mRFP delGli transgenic fish fewer mRFP-positive 
cells were observed within the CMZ, suggesting that the loss of the Gli TFBS resulted in a shift of 
expression towards the RPE rather than an expansion. These results demonstrate that inhibitory 
factors confine Rx2 to the RSCs in the CMZ and prevent expression in the proliferating cells of the 
RPE. Furthermore, the Gli-binding site is of importance within the CMZ for the trans-activation of Rx2.
Figure 20. Loss of the Gli-binding site in the Rx2 CRE shifts reporter expression into the RPE.
(A-A’’’) Confocal stacks of frontal sections on the retina of Rx2::H2B-mRFP transgenic embryo 9 dpf. 
Immunostaining against nuclear mRFP shows transgene expression in the controls as expected in the CMZ, INL 
and ONL (A, red). Expression of the transgene is confined to the CMZ and does not extend to the RPE (A’’, red). 
Higher magnification pictures of boxed regions (A) are shown in (A’-A’’’).
(B-B’’’) Confocal stacks of frontal sections on the retina of Rx2::H2B-mRFP delGli transgenic embryo 9 dpf. 
Deletion of putative Gli-binding site in the Rx2 CRE causes ectopic transgene expression in cells of the RPE and 
reduces expression in the CMZ (B’’). Higher magnification pictures of boxed regions (B) are shown in (B’-B’’’). 
Yellow dashed line demarcates border between RPE and CMZ. Scale bars: 50 μm in A and B; 25 μm in A’ and B’.
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2.2 Elucidating Rx2 function
2.2.1 Gain of Rx2 in the medaka retina
To address the function of Rx2 itself, the effect of Rx mis-expression was studied in vivo. For this 
purpose, a single mRNA encoding Rx2 and mRFP separated by a sequence for a viral T2A cleavage 
site was engineered (Rx2-T2A-mRFP), resulting in the equal proportions of (separate) Rx2 and mRFP 
proteins. The regulatory element of Atoh7 (Del Bene et al. 2007) was chosen to express Rx2-T2A-
mRFP. Atoh7 is involved in specification of RGCs during early neurogenesis in the retina (Kanekar 
et al. 1997; Brown et al. 2001; Wang et al. 2001; Kay et al. 2005) and, as described above, later 
demarcates the central-most CMZ, where cells exit the cell cycle and terminally differentiate (Cerveny 
et al. 2010). In addition the Atoh7 CRE is also active in a fraction of differentiated cells of the post-
embryonic retina. As a result, the transgene Atoh7::Rx2-T2A-mRFP was expressed in post-mitotic 
precursors (at embryonic and post-embryonic stages) as well as neurons in the GCL and INL. 
2.2.1.1 Rx2 gain-of-function in the Atoh7 domain results in morphological changes in the 
GCL and INL
Cross-sections of transgenic Atoh7::Rx2-T2A-mRFP hatchlings were characterized by apical 
extensions of the GCL. Furthermore, the INL was extended towards the GCL (basally), resulting in 
irregular spacing between the two layers. These extensions were inhabited by mRFP-positive cells 
and distributed at similar positions in GCL and INL along the dorsal-ventral axis of the sectioned 
retinae (Figure 21A-D). In the most severe cases, the IPL, usually free of cell nuclei, was populated by 
cells, which formed continuous connections between the GCL and INL (Figure 21E-H). In all retinae 
analyzed, multiple extensions were found along the apical surface of the GCL and basal surface of 
the INL. On average, 3.67 positions across the IPL were irregular spaced per section (3.67±1.37, six 
sections). Two independent transgenic lines with the same transgene (Atoh7::Rx2-T2A-mRFP) were 
established, similar in pattern but different in level of mRFP expression due to their varying copy-
numbers and different positions of insertion into the genome. While embryos of both lines displayed the 
phenotype described above, the length of the extensions along the apico-basal axis entering the IPL 
was increased in offspring with stronger mRFP expression (not shown). Since Rx2 and mRFP originate 
from the same mRNA and therefore the translation of both proteins is stoichiometrically equivalent, 
increased expression of mRFP is indicative of higher Rx2 levels. Enucleated eyes from Atoh7::Rx2-
T2A-mRFP transgenics were undistinguishable from control eyes in their external morphology. 
To test whether proliferation is altered in retinae over-expressing Rx2, a 24 h (at day 9) pulse of BrdU 
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was provided without a chase (fixed at day 10). With the exception of the cells inside and surrounding 
the optic nerve, no BrdU-positive cells were detected in the central retina of Atoh7::Rx2-T2A-mRFP 
transgenics (Figure 21E-H). These findings were similar to wild-type controls treated in parallel (not 
shown). Inside the CMZ, where ectopic Rx2 was expressed in the central-most cells, incorporation 
of BrdU was limited to the transit-amplifying domain (white arrowhead in Figure 21I-L). Similarly, a 
short pulse resulted mainly in BrdU uptake in rapidly dividing progenitors in between peripheral and 
central CMZ of control retinae. The irregular spacing of the nuclear layers was not accompanied by 
cell divisions in cells expressing Rx2-T2A-mRFP, hinting at either ectopic proliferation occurring earlier 
during development or that the phenotype seen in Atoh7::Rx2-T2A-mRFP transgenics is established 
independent of changes in proliferation. 
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Figure 21. Gain of Rx2 in the Atoh7 domain does not coincide with enhanced proliferation.
(A-L) Confocal stacks of frontal sections showing the central retina of transgenic Atoh7::Rx2-T2A-mRFP fish 
10 dpf. BrdU was provided for 24 h prior to fixation. Rx2-T2A-mRFP (B, F, J, red) expression induces irregular 
spacing between the GCL and INL. No cell divisions outside of the CMZ and optic nerve occurred during the 24 
h BrdU pulse (C, G, K, green). Higher magnification pictures of boxed regions (A) are shown in (E-H and I-L). 
Asterisks (yellow) indicate irregular layering. White arrowheads highlight outer margin of the Atoh7 expression 
domain. Scale bars: 50 μm in A; 10 μm in E and I.
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2.2.1.2 Rx2 gain-of-function does not alter proliferation and morphology during the beginning 
of retinal differentiation
To assess the dynamics in the phenotype caused by Rx2 mis-expression, earlier stages of eye 
development, in particular during the onset and progression of retinal neurogenesis were examined in 
Atoh7::Rx2-T2A-mRFP transgenic embryos.
At 2.5 dpf Rx2-T2A-mRFP was ectopically expressed throughout the GCL and in very few cells on the 
basal surface of the future INL (Figure 22A-H). Similarly, transgene expression at 3.5 dpf was detected 
in the GCL and INL (Figure 22I-P). At both stages analyzed, mRFP-expressing cells clustered together 
in small groups at the basal surface of the INL (yellow asterisks in Figure 22). Additionally, weak mRFP 
signal was detected in a small number of individual cells of the ONL. Compared to retinae at 2.5 dpf, 
more mRFP-positive cell cluster were detected in the INL at 3.5 dpf. 
Cells passing through the S-phase of the cell cycle were localized at the periphery of the NR at 2.5 
dpf and 3.5 dpf (Figure 22). Neither during 24 h (fixed at 2.5 dpf) nor 48 h pulses (fixed at 3.5 dpf) was 
BrdU incorporated in Rx2 over-expressing cells. In terms of morphology and proliferation these retinae 
did not differ from stage-matched wild-type controls (not shown). In particular, the spacing between 
GCL and INL was similar to the controls, arguing for the phenotype being established at later stages 
of embryonic retinogenesis.
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Figure 22. The Rx2-mediated layering phenotype is not established during early retinogenesis.
(A-H) Confocal stacks of transversal sections showing the central retina of transgenic Atoh7::Rx2-T2A-mRFP 
fish 2.5 dpf. BrdU was provided for 24 h prior to fixation. Rx2-T2A-mRFP-expressing (red, B, F) cells occur in 
cluster in the INL. No cell divisions outside of the CMZ were observed in the NR. 
(I-P) Confocal stacks of transversal sections showing the central retina of transgenic Atoh7::Rx2-T2A-mRFP fish 
3.5 dpf. BrdU was provided for 48 h prior to fixation. Rx2-T2A-mRFP-expressing (red, J, N) cells occur in cluster 
in the INL. No cell divisions outside of the CMZ were observed in the NR. Higher magnification pictures of boxed 
regions (A and I) are shown in (E-H and M-P). Asterisks (yellow) indicate irregular layering. Scale bars: 50 μm in 
A and I; 10 μm in E and M.
2.2.1.3 Rx2 expression under the Atoh7 CRE coincides with reduced expression of markers 
for neural differentiation of RGCs
The proneural gene Atoh7 encodes a basic helix-loop-helix TF crucial for the genesis of RGCs. Atoh7 
has the ability to activate itself through an auto-regulatory feedback loop; the TF recognizes and binds 
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the Atoh7 CRE to mediate expression (Matter-Sadzinski et al. 2001; Del Bene et al. 2007). Other 
known targets of Atoh7 include Hu antigen C (HuC, ELAV-like 3) Brn3C and CD166. Atoh7 is able to 
trans-activate HuC expression via direct binding to an E-box motif in the proximal regulatory element 
(Del Bene et al. 2007). To investigate the molecular mechanism behind the phenotype in the post-
embryonic retina of Atoh7::Rx2-T2A-mRFP transgenics, HuC as a known Atoh7 target gene and Islet 
as a RGCs marker (Martinez-Morales et al. 2001) were assessed through immunostainings. At 10 dpf 
when embryonic neurogenesis was concluded, cells in GCL with strong Rx2 expression (as indicated 
by the mRFP) had reduced levels of HuC/D protein (Figure 23A-A’’’’). Similarly, weak immunostainings 
for Islet coincided with high mRFP expression, while high Islet levels occurred in cells with no or little 
mRFP expression (Figure 23B-E).
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Figure 23. Rx2 overexpression in RGCs coincides with reduced expression of markers for RGCs.
(A-E) Confocal stacks of transversal sections showing the central retina of transgenic Atoh7::Rx2-T2A-mRFP 
fish 10 dpf. 
(A-A’’’’) Rx2-T2A-mRFP (red, A’’) expression coincides with reduced staining for the RGC-marker HuC/D (green, 
A’’’). 
(B-E) Rx2-T2A-mRFP (red, C) expression coincides with reduced staining for the RGC- and AC-marker Islet 
(green, D). Asterisks (yellow) indicate absence of Rx2-T2A-mRFP in strongly HUC/D- or Islet-positive cells in the 
GCL. Yellow arrowheads indicate Rx2-T2A-mRFP-expressing cells with no or less HuC/D (or Islet) in the GCL. 
Scale bars: 50 μm in A; 10 μm in A’ and B.
2.2.1.4 Reduced activity of the Shh regulatory element in the GCL coincides with Rx2 gain-of-
function
Having shown above that downstream mediators of the Hh pathway regulate Rx2 expression, the 
impact of gain of Rx2 in cells with active Hh signaling was evaluated. For this purpose double transgenic 
offspring from a cross between Atoh7::Rx2-T2A-mRFP and Shh::GFP carriers were analyzed. Siblings 
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expressing only Shh::GFP were used as the control. The zebrafish regulatory element of Shh (Neumann 
and Nuesslein-Volhard 2000) introduced upstream of GFP resulted in reporter gene expression in 
the GCL and INL in hatchlings (Figure 24A-H). Thus, the observed reporter expression in transgenic 
medaka embryos was consistent with studies in other vertebrate species detailing Shh expression in the 
NR (Wallace 2008). Given that the Atoh7 CRE is primarily active in the RGCs, offspring carrying both 
transgenes should co-express Rx2-T2A-mRFP and GFP in the GCL. On average 12.5 GFP-positive 
cells (12.5±2.43, six sections) were detected in the GCL of Shh::GFP hatchlings (yellow asterisks in 
Figure 24A-H). In contrast, this number was reduced to 2.5 cells (2.5±1.05, six sections) in the GCL 
of Atoh7::Rx2-T2A-mRFP / Shh::GFP transgenics (yellow asterisks in Figure 24I-P). The number of 
GFP-positive cells in INL of double-transgenic hatchlings (13.67±2.88, six sections) was similar to the 
average number in control siblings (13±4.56, six sections). The findings show that the non-conditional 
expression of Rx2 coincided with lower activity of the Shh promoter. 
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Figure 24. Expression of Rx2 in the GCL reduces Shh promoter activity.
(A-H) Confocal stacks of transversal sections showing the central retina of transgenic Shh::GFP fish 9 dpf. The 
Shh promoter (green, C, G) is active in the GCL and INL.
(I-P) Confocal stacks of transversal sections showing the central retina of double transgenic Atoh7::Rx2-T2A-
mRFP and Shh::GFP fish 9 dpf.  Rx2-T2A-mRFP expression (red, J, N) coincides with reduced number of cells 
with Shh reporter expression (green, K, O). Higher magnification pictures of boxed regions (A and I) are shown 
in (E-H and M-P). Asterisks (yellow) indicate GFP-positive cells in GCL. Scale bars: 50 μm.
2.2.2 Rx2 loss-of-function
Rx2 has been established as a molecular marker for multipotent NSCs in the adult fish retina. However, 
the function of Rx2 remains unknown. To accurately gauge the role of Rx2, loss-of-function studies 
are inevitable. Morpholino oligonucleotides directed against the start codon of Rx2 failed to produce 
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phenotypes (not shown). Instead of changing Rx2 protein levels by means of mRNA knockdown 
strategies, we aimed for the permanent genetic inactivation of Rx2 through locus-specific disruptive 
mutations.
For this purpose two customized TALEN pairs were designed against the coding sequence of the Rx2 
gene. TALENs 128 and 129 TALEN consist of DNA binding domains matching the first coding exon of 
Rx2 (Figure 25A). The TAL effectors of pair 106/107 were designed to bind the second exon (Figure 
25A). Analysis of the protein domains encoded in the Rx2 gene showed TAL effectors 128 and 129 
binding in between the sequence of the octapeptide domain and the homeobox (Figure 25B). TALENs 
106 and 107 were binding in the middle of the homeobox. Depending on the nature of mutations, 
TALEN-mediated changes in the exonic sequences could result different truncated protein variants. 
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Figure 25. TALEN pairs 106/107 and 128/129 align perfectly with the Rx2 coding sequence.
(A) Result of BLAST search for the two TALEN pairs against the medaka genome in the Ensembl browser. The 
Rx2 gene is located on chromosome 17 of the genome and the transcript consists of three coding exons (dark 
red). One small additional coding exon is included in an alternative Rx2 transcript. All four TALEN DNA binding 
domains (red) align free of mismatches to exonic Rx2 sequences.
(B) The annotated coding sequence of Rx2 results in a single ORF (orange). The binding sequences (green) 
of 106/107 align to the sequence encoding the homeodomain (grey). 128 and 129 (green) bind upstream of 
the homeobox and downstream of the octapeptide domain (grey). Restriction enzymes BspEI and HpaII (grey 
triangular pyramids) were used for the band-retaining assays.
2.2.2.1 TALEN pairs 106/107 and 128/129 introduce locus-specific DNA breaks in the Rx2 cod-
ing sequence
To test whether the TALENs are able to accomplish the desired genomic modifications, wild-type 
embryos were co-injected with TALEN mRNAs at one-cell stage and genotyped prior to hatching. For 
the genotyping process genomic DNA from injected embryos was isolated. The predicted TALEN target 
regions were specifically amplified and tested in restriction digest-based band-shift assays (Figure 26). 
Mutations in sub-cloned retained bands were confirmed in sequencing reactions. 
One clone (1/1, 100%) for the pair 128/129 was sequenced, aligned with the Rx2 locus and carried a 
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mutation (Figure 27A). The deletion in between the predicted TALEN binding sites was 5 base pairs, 
which resulted in a frame shift and a truncated Rx2 protein with 101 amino acids (wild-type Rx2 protein 
consists of 328 amino acids). For TALENs 106 and 107, 15 out of 16 (15/16, 93.75%) sequenced 
clones from seven individual embryos contained mutations in between the binding sites (Figure 27B). 
The mutations were deletions of either 4 or 10 base pairs, all causing frame shifts in the ORF and in 
theory producing truncated Rx2 proteins. This shows that both TALEN pairs induce disruptive mutations 
in their respective binding domains of the Rx2 coding sequence upon injection at one-cell stage.
1000 bp
BspEI
128 / 129
* * * *
L 1 21 2
+ -- +
Figure 26. Band-retaining assay on isolated genomic DNA of injected medaka fish.
Amplified PCR products from injected fish (F0) were digested with a restriction enzyme cutting in between the 
binding sites of the TALENs (HpaII for TALENs 106/107, BspEI for 128/129). Retained bands (identical in size to 
the undigested PCR product) were isolated from the gel (yellow arrowheads), sub-cloned and confirmed through 
sequencing. A fraction of the amplified products were not mutated and therefore digested by the restriction 
enzyme (yellow asterisks). L, ladder; bp, base pairs.
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injected
wt
consensus
Figure 27. Alignments of sequenced clones (F0) with the Rx2 coding sequences.
(A) Genomic DNA isolated from injected embryo contains deletion of base pairs between binding sites of TALENs 
128 and 129.
(B) Several sequenced clones show a variety of modifications caused by TALEN (106 and 107) co-injection. 
One clone is aligned perfectly with the Rx2 sequence of interest, meaning no modification was created on this 
genomic DNA.
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2.2.2.2 TALENs 106/107 and 128/129 induce heritable Rx2 mutations
In order to determine whether the customized TALENS efficiently create mutations in the endogenous 
Rx2 gene in medaka germ cells and in turn pass them on to the following generation, the offspring 
of injected fish were genotyped. Injected F0 embryos were raised to adulthood and crossed to wild-
type fish. Collected offspring (F1) from each cross were divided in two halves; one group was raised 
to adulthood, while the rest was pooled and genotyped as outlined above for the F0 generation. 
This approach was chosen to detect whether the injected fish are carriers and therefore the TALENs 
induced genomic modifications in the germline. Eight outcrosses with TALEN 106 and 107 injected 
fish were genotyped (Table 2). In four of these crosses alteration in the target region were detected. All 
deletions observed in the sequencing process were 10 base pairs in size. Regarding putative founders 
from 128/129 injections, two out of two crosses produced offspring with mutations in Rx2. Sequencing 
revealed at least two different types of mutations (6 and 9 base pair deletions) in the offspring of the 
two founders  (Figure 28). The observed deletions of 6 and 9 base pairs were both in frame, therefore 
resulting in the deletion of entire amino acids instead of a shift in the ORF. The analyses of the F1 
generation revealed heritable targeted gene disruption can be created with both pairs of TALENs.
individual 
outcrosses
n clones mapping 
to the Rx2 gene
n of clones with 
mutations
percentage 
of mutations 
identified
1. 7 1 14.29
2. 6 0 0
3. 8 4 50
4. 5 1 20
5. 6 3 50
6. 5 0 0
7. 6 0 0
8. 4 0 0
total 47 9 19.15
Table 2. Overview of analyzed offspring from outcrosses between fish injected with TALENs 106/107 and 
wild-type fish.
The offspring from four (bold) of the eight injected (TALENs 106/107) fish inherited lesions in the targeted Rx2 
sequence.
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Figure 28. Alignments of sequenced clones (F1) with the Rx2 coding sequences.
Two adult medaka fish were (injected with TALENs 128 and 129) were outcrossed to wild-type fish and their 
progeny were genotyped. The sequenced clones show a variety of heritable modifications. One clone is a false-
positive and aligns perfectly with the Rx2 sequence of interest, meaning no modification was created on this 
genomic DNA.
2.2.2.3 TALENs 106 and 107 show mutagenesis activity on the homeobox of Rx1 and Rx2
The homeodomain is a well-conserved protein structure among various animals, including vertebrates 
(Gehring 1992). Given that Rx2 has two paralogs (Rx1 and Rx3) in the medaka genome, we 
explored whether the TALENs designed for Rx2 recognize other Rx coding sequences. Alignment 
of the homeoboxes of Rx1 and Rx2 with the TALE effector binding sites showed perfect match with 
TALEN 106. For TALEN 107, three mismatches were found when compared with Rx1 (Figure 29A). 
Nevertheless, we addressed whether this particular TALEN pair is able to induce lesions in this specific 
region of the Rx1 gene. The genotyping process (genomic DNA was isolated from the fins of adults) on 
the F1 generation was repeated using specific primers for the Rx1 homeobox. Sequencing of picked 
DNA clones revealed deletions in Rx1 in within the predicted target region of the homeobox flanked by 
TALE effectors 106 and 107 (Figure 29B), arguing for the chance to induce TALEN-mediated mutation 
with partially mismatching binding domains. Furthermore, this opens the possibility to generate and 
analyze Rx1 mutant fish.  
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Figure 29. TALENs 106/107 introduce heritable modifications in the Rx1 homeobox.
(A) Alignment of Rx1 and Rx2 coding sequences for the TALE effector binding sites. TALEN 106 matches perfectly 
to Rx1 and Rx2, while TALEN 107 only aligns without mismatches to Rx2.
(B) Amplification of Rx1 homeobox sequence from genomic DNA of adult fish (F1) was sub-cloned and sequenced. 
Disruptive mutation in Rx1 was caused by TALEN (106 and 107) co-injection and passed on through the germline. 
The fraction of the offspring (F1) collected from the injected F0 generation, which were grown to 
adulthood, was genotyped (genomic DNA isolated from the fins) (Table 3). Out of the twelve mutant 
fish eleven had deletions in Rx1 and four in Rx2. With the exception of the Rx2 target site of carrier 8, 
all deletions in the predicted target sites were 10 bases in size. Translation of the mutant sequences 
in silico contained frame-shifts, resulting in truncated Rx1 or Rx2 proteins. The deleted 6 bp in Rx2 
of mutant fish 8 were in frame, removing two amino acids in the homeodomain. A low frequency of 
sequenced clones contained single base pair substitutions or indels upstream or downstream of the 
predicted TALEN target region. These unexpected modifications were present in sequences with and 
without the desired modifications in the Rx1 or Rx2 target site. F1 mutant carriers with the intended 
modifications in the Rx1 target sequence were occasionally accompanied by additional deletions of 
6 consecutive bases. All instances of these unpredicted genetic events in Rx1 mapped at the same 
position, approximately 60 nucleotides upstream of the TALEN 106 binding site. In contrast, sequencing 
reads of the Rx1 homeobox free of genomic modifications in the TALEN target site, which were false-
positives from the band-retaining assay, never missed 6 base pairs upstream or downstream of the 
predicted TALEN binding sites.
The fish carrying mutations leading to a frame shift in Rx1 or Rx2 were outcrossed to wild-type medaka. 
The offspring (F2) of genotyped individual F1 carriers of Rx1 and Rx2 mutations are currently being 
raised to adulthood. For the molecular analysis of the Rx1 or Rx2 genes, heterozygous siblings (F2) 
will be intercrossed to homozygosity. So far, the phenotype of homozygous Rx1 and Rx2 mutant fish 
remains to be determined. 
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F1 fish gene n of mapped 
clones 
n of clones 
with 
mutations
size of 
deletion in 
the target 
sequence
other genomic 
modifications
1. Rx1 3 1 10 bp additional 6 bp del 
Rx2 3 2 2 bp additional A nt
2. Rx1 3 1 10 bp additional 6 bp del 
Rx2 7 0
3. Rx1 3 2 10 bp
Rx2 3 3 10 bp
4. Rx1 4 4 10 bp
Rx2 1 0
5. Rx1 2 2 10 bp additional 6 bp del 
Rx2 5 0
6. Rx1 3 2 10 bp
Rx2 0 0
7. Rx1 3 3 10 bp
Rx2 4 0 one clone with 
additional T 
8. Rx1 3 2 10 bp same reads having 10 
bp del have also 1 nt 
substituted
Rx2 3 2 6 bp
9. Rx1 5 0
Rx2 2 1 10 bp same read having 10 
bp del has also 1 nt 
substituted
10. Rx1 3 2 10 bp
Rx2 6 0
11. Rx1 4 3 10 bp
Rx2 1 0
12. Rx1 3 1 10 bp
Rx2 3 0
Table 3. Overview of Rx1 and Rx2 mutations in genotyped adult F1 (F0 injected with TALENs 106/107).
Summary of the results obtained from genotyping. Genomic modifications in each individual fish were determined 
for the predicted target region in the Rx1 and Rx2 homeoboxes (bold). The number of modified nucleotides inside 
the target as well as outside is listed.
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2.2.2.4 TALEN-induced mutants recapitulate eyeless phenotype
When injected F0 fish were raised to adulthood and inter-crossed, a fraction of the progeny (F1) from 
some of these crosses repeatedly exhibited a phenotype in the eye. These embryos were identified by 
small or absent optic cups during embryogenesis. Embryos screened at late gastrula and early neurula 
stages showed incompletely formed or missing optic vesicle, resembling phenotypes of mutants for 
genes involved in early eye field patterning and vesicle evagination such as Rx3 or Pax6. Given that 
TALENS 106 and 107, which targeted the homeobox of Rx2, produced mutations in Rx1 as well as 
Rx2, it was a strong possibility that disruptive lesions were introduced in the coding sequence of Rx3. 
To test this hypothesis without the genotyping process, fish co-injected with TALEN 106 and 107 
mRNAs at one-cell stage (F0) were crossed to wild-type fish. In the following generation (F1), the 
offspring were crossed, without prior genotyping, to heterozygous eyeless mutant carriers. Eyeless 
mutants harbour a recessive, temperature-sensitive mutation in the Rx3 locus. Homozygous eyeless 
embryos raised at the restrictive temperature show smaller or absent eyes (Winkler et al. 2000; Loosli 
et al. 2001). Out of all the F1 fish outcrossed to known eyeless+/- carriers so far, one (out of 12) 
produced offspring with an eye phenotype. All embryos collected from this particular cross of TALEN 
106/107 fish and eyeless founders were raised at the permissive temperature, however, more than 
22% (5/22, 22.73%) of the collected offspring morphologically resembled Rx3-/- mutants and showed 
phenotypes ranging from small eyes to the complete lack of eyes (Figure 30). As early as neurula 
stage embryos exhibited phenotypes in the forming eye (not shown), the most severe cases showing 
a complete failure to form optic vesicles. Mutants with small optic cups (Figure 30B) failed to develop 
normal sized retinae, instead the eye remained small yet underwent pigmentation (Figure 30D), while 
the overall body shape and size (excluding the eyes) was similar to wild-type or heterozygous siblings 
(Figure 30C). This morphological analysis of the offspring from a cross between TALEN 106/107+/- and 
eyeless+/- founders recapitulates the phenotype described for homozygous Rx3 mutants. 
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Figure 30. Cross of TALEN 106/107-injected progeny and heterozygous Rx3 carriers results in eyeless 
phenotype.
(A-D) Dorsal view of medaka embryos in the brightfield. Close to a quarter of the siblings at optic cup stage 
exhibit small or absent optic cups (B), while the remaining collected embryos show wild-type morphology (A). The 
mutant embryos continue development with small or no eyes (D), as the siblings go through retinogenesis and 
form a properly differentiated eye (C). All images were obtained with the same magnification.
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3 Discussion
3.1 A regulatory framework containing Sox2, Tlx, Gli3 and Her9 controls 
stem cell features in the retina
3.1.1 Sox2 and Tlx positively regulate stem cell features in the retina
Previous studies have highlighted the importance of Sox2 and Tlx for NSCs and progenitors. Sox2 
plays a crucial role in maintaining neural precursors in an undifferentiated state and suppressing 
terminal differentiation (Bylund et al. 2003; Graham et al. 2003; Van Raay et al. 2005; Taranova et al. 
2006). Consistent with reports of the pan-neural determinant Sox2 being expressed in self-renewing 
and multipotent adult NSCs in the brain (Suh et al. 2007), expression in the retina labeled the CMZ 
including the Rx2 domain. Tlx has been demonstrated to be expressed in neural progenitors in the 
developing retina and brain, as well as mitotically active cells in the adult brain of mammals (Yu et 
al. 1994; Monaghan et al. 1995; Shi et al. 2004). Genetic inactivation has highlighted the role of Tlx 
in retinal development as well as in keeping adult NSCs and precursors in a proliferative state (Yu et 
al. 2000; Shi et al. 2004). Tlx expression was partially overlapping with Rx2, but mainly observed in 
the centre of the CMZ, where the transiently amplifying progenitors are located, reminiscent of the 
expression reported in the mouse brain (Obernier et al. 2011).
The present study provides evidence that both Sox2 and Tlx have the ability to induce RSC characteristics 
in terminally differentiated neurons of the post-embryonic retina. We found the RSC-specific marker 
Rx2 upregulated in clonal overexpression assays, with the highest rate of trans-activation achieved 
by co-expression of Tlx and Sox2. Sox proteins are involved in a great variety of cell specifications 
and depend on interaction with process-specific partner proteins (Kondoh and Kamachi 2010). For 
instance, ectopic Rx CRE activity had previously been shown to be the result of the collaborative 
effort between Sox2 and Otx2; however, in contrast to our findings regarding the medaka Rx2 CRE, 
Sox2 overexpression on its own was not sufficient to trans-activate the Xenopus Rx CRE (Danno et 
al. 2008). Otx2, which has been reported to play a critical role in photoreceptor cell development in the 
embryonic mouse retina (Nishida et al. 2003), could still be involved in regulation of Rx2 expression at 
early developmental stages or in post-mitotic cells. Interestingly, studies in mice on the Otx2 regulatory 
element revealed Rx as an activator (Muranishi et al. 2011), which suggests an independent regulatory 
network governing commitment of RPCs towards photoreceptor cell fate. Recent studies carried out in 
NSCs have shown that Sox2 expression induces Tlx expression (Shimozaki et al. 2012). Furthermore, 
direct interaction between Sox2 and Tlx proteins relieved a negative feedback loop on the Tlx promoter. 
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Therefore, it is possible that a similar protein-protein interaction between Sox2 and Tlx synergistically 
regulates Rx2 expression in the context of the retina. While it has been shown that Tlx in general acts 
as a transcriptional repressor through interaction with HDACs to maintain neural precursors in an 
undifferentiated state (Sun et al. 2007), the TF Tlx is also able to directly activate target genes when 
associated with co-activators instead of HDACs (Elmi et al. 2010). Thus, it is possible that Tlx induces 
Rx2 expression either through activation of transcription or repression of an Rx2 repressor.
Upon clonal activation of Rx activators, terminally differentiated cells lost their differentiation markers, 
re-entered S-phase and rested in a proliferatively quiescent state, a general hallmark of adult stem 
cells (Orford and Scadden 2008). The appearance of mitotic markers and morphological changes 
in differentiated neurons argues for loss of neuronal identity. Moreover, after transient exposure to 
Tlx, cells retained fluorescent labels for multiple weeks, suggesting altered cell metabolism or protein 
turnover. In comparison, in the control experiments no transiently expressed fluorescent labels were 
retained in post-mitotic neurons several weeks after the expression was discontinued.
However, we did not observe increase in clone size or cell divisions, even when Sox2 and Tlx were 
co-expressed. Instead, neurons showed RSC-specific features without proliferating. This is agreement 
with results from previous reports, where Sox2 or Tlx gain-of-function experiments were conducted 
in undifferentiated stem cells or progenitors of the CNS, even though not in differentiated neurons 
as in the present study. Although it has been recently demonstrated that Sox2 is sufficient to convert 
mouse and human fibroblasts into induced NSCs (Ring et al. 2012), Sox2 overexpression in retinal 
progenitors of frog and mouse does not induce proliferation, instead, progenitors increasingly commit 
to post-mitotic MGC fate (Agathocleous et al. 2009; Lin et al. 2009). In mammalian neural progenitors 
and stem cells, Tlx overexpression has been shown to transiently enhance proliferation; however, 
even there sustained Tlx expression is necessary for persisting effects and was not tested in terminally 
differentiated neurons (Elmi et al. 2010; Liu et al. 2010). 
In light of the results presented here, we hypothesize that transient gain of Sox2 or Tlx mediates de-
differentiation into a quiescent RSC-like state, but is not sufficient to trigger proliferation of terminally 
differentiated neurons. Rather, prolonged expression or combination with other factors, for instance 
cell cycle activators (Agathocleous et al. 2009), is required for post-mitotic neurons to complete the 
entire cell cycle and divide.
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3.1.2 Gli3 and Her9 overexpression in the CMZ antagonizes Rx2 and stem cell 
proliferation
In the frog retina ligands of the Hh signaling pathway are expressed in the GCL and the central RPE. 
The key transcriptional regulators of the cascade, zinc-finger containing Gli TFs, are expressed at a 
distance to the source at the boundary between NR and RPE (Borday et al. 2012). Consistently, we 
found full-length Gli3, which encodes a repressor and activator-domain, expressed in the peripheral 
RPE and peripheral CMZ. In absence of Hh signaling, Gli3 is proteolytically cleaved and functions as a 
transcriptional repressor of Hh target genes. In the event of Hh signal transduction, proteolytic processing 
is inhibited, and Gli3 translocates to the nucleus to activate Hh target gene transcription (Humke et al. 
2010). Clonal expression of Gli3 in the peripheral CMZ repressed Rx2 transcription arguing for only 
restricted Hh signaling activity in that domain. Additionally, we found a decrease of RSCs in S-phase 
after exposure to Gli3, reminiscent of results in the chicken neural tube, where dominant-negative 
Gli3 delays cell cycle progression and decreases expression of mitotic markers (Cayuso et al. 2006). 
Consistent with our findings in the CMZ, Gli3 regulates the proliferative expansion of mesenchymal 
progenitors through restriction of their entry into S-phase during chondrogenesis (Lopez-Rios et al. 
2012). Similarly, the blocking of the Hh cascade has been reported to impact on the cell cycle exit of 
retinal progenitors cells in fish and frogs (Locker et al. 2006). Interestingly, pharmacological inhibition 
of Hh signaling is not sufficient to modulate Rx expression in the CMZ of frog (Locker et al. 2006; 
Borday et al. 2012). The finding that Gli3 and Rx2 share expression in the peripheral CMZ, while 
the peripheral RPE is simultaneously occupied by Gli3 only, suggests a dual role for the TF Gli3 as 
activator and repressor. 
In our gain-of-function assays full-length Gli3 acted as a repressor of Rx2 and inhibited proliferation, 
although it also encoded an activator domain. This indicates limited levels of Hh signaling likely due to 
the distance to the source of Hh ligands in the GCL (Neumann and Nuesslein-Volhard 2000; Stenkamp 
et al. 2000), resulting in an accumulation of Gli3 in the repressive form. 
Similarly, acute and sustained expression of Her9, a Hes1 ortholog in fish, in the peripheral CMZ 
reduced Rx2 levels and proliferation. This finding is surprising since Hes genes have generally 
been reported to antagonize proneural function and are required to keep neural progenitor cells in 
a proliferative state (Kageyama et al. 2007). However, it has been demonstrated that persistent and 
high levels of Hes1 expression inhibit both cell proliferation and differentiation (Baek et al. 2006). 
Furthermore both, sustained gain or loss of Hes1 activity causes G1 phase retardation, resulting in 
reduced cell proliferation (Yoshiura et al. 2007). Thus, the loss of proliferation upon exposure to high 
levels of Her9 likely represents a pausing of cell cycle progression and failure to enter S-phase. We did 
64
Discussion and Outlook
not detect apoptosis in clones with reduced proliferation in response to Gli3 or Her9 over-expression 
(not shown). Furthermore, these cells did not express any markers characteristic for neurons or glia 
(not shown), again arguing for a pausing of the cells. 
3.1.3 The RSC-specific expression of Rx2 is sustained through conserved Sox- 
and Gli-binding sites
Our analysis of the Rx2 CRE indicated that Sox-binding is crucial for Rx2 expression in RSCs of the 
CMZ as well as for MGCs. Mutations in a Sox-binding site of the Rx2 CRE resulted in the massive 
reduction of reporter expression in the CMZ and MGCs, consistent with the expression of Sox2 
transcripts in the CMZ and INL described above. In contrast, the expression in photoreceptors, where 
Sox2 is not expressed, remained unaffected. Our data are consistent with and extending previous 
studies on the CRE of Xenopus Rx. Combined mutations in the Sox- and Otx-binding sites resulted 
in reduced reporter activity in the frog CMZ (Martinez-De Luna et al. 2010), however, the impact of 
mutations in either the Sox- or Otx-motif was not shown. Experiments carried out in cultured cells have 
shown that physical interaction and binding of the TFs Sox2 and Otx2 sustain activity of the Xenopus 
Rx CRE (Danno et al. 2008). However, Otx2 transcripts were absent from the mature medaka CMZ 
(not shown). Since a putative Otx-binding has been predicted in the medaka Rx2 CRE (M. Ramialison, 
unpublished), it is a possibility that Otx trans-acting factors are involved in Rx2 regulation, for instance 
during embryonic stages of eye development. 
The finding that reporter expression controlled by the mutated CRE was not fully absent suggests that 
Rx2 expression in the CMZ is not entirely dependent on trans-acting factors, which utilize the Sox-
binding site, but rather that Rx2 expression in the CMZ is the result of multiple regulatory inputs. Given 
the ability of Tlx to activate the Rx2 regulatory element and their overlapping expression domains, it 
is possible that Tlx is also directly involved in Rx2 regulation in the NR. Future experiments predicting 
and testing Tlx-binding motifs will address the role of direct Tlx-binding for correct Rx2 expression. 
Alternatively, the base pair substitutions in the Sox-binding site might not be sufficient to completely 
abolish Sox protein interaction with the Rx2 CRE. Analyzing Rx2 reporter expression after deletion of 
the entire Sox-motif could test this hypothesis. Out of the three members of the Sox B1 sub-group only 
Sox2 was expressed in the CMZ, supporting the hypothesis that Sox2 is the TF acting through the 
mutated binding site in vivo. Interestingly, mutation of the Sox-binding site also affected Rx2 reporter 
expression in the MGCs, the reservoir of quiescent stem cells in the central NR (Bernardos et al. 
2007). With Rx being necessary for wound-regeneration in the Xenopus retina (Martinez-De Luna et 
al. 2011), this finding indicates a similar regulatory scaffold governing quiescence in the peripheral 
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CMZ and injury-free NR.
Conversely, upon deletion of a putative Gli-binding site, reporter expression was shifted towards the 
RPE. Here it was restricted to cells adjacent to CMZ, the domain of Gli3 expression. In contrast to 
cells in the central RPE, they continue to proliferate beyond the conclusion of embryogenesis, similar 
to RSCs in the CMZ. Combined with the results showing that Gli3 is a Rx2 repressor in vivo, it is 
tempting to speculate that Gli3 is the TF acting through the deleted binding-site and responsible for 
preventing Rx2 CRE activity in the RPE. This way it confines Rx2 expression to the CMZ and blocks it 
from entering the RPE. The shift of Rx2 reporter expression in the CMZ upon deletion of the Gli-binding 
site is intriguing. It indicates a dual function of this Gil-binding site, mediating repressive activity in the 
RPE as well as transcriptional activation in the directly adjacent CMZ. Upon deletion of the Gli-binding 
site, the loss of repression resulted in the gain of Rx2 reporter expression in the RPE, while the loss 
of activation in the CMZ abolishes Rx2 reporter expression in that domain. As an alternative to Gli3, 
the reduced activation in the CMZ could also be attributed to another trans-acting factor requiring the 
deleted DNA motif. For instance, the transcriptional activator Gli1 is expressed in the CMZ (not shown) 
and has been shown to share overlapping activating functions with Gli3 during vertebrate neurogenesis 
(Tyurina et al. 2005). Further, it has been demonstrated that input from both Gli1 and Sox2 is required 
for precise neural enhancer activity in the mammalian neural tube (Peterson et al. 2012), raising the 
possibility that similar cross talk between signal transduction cascades and neural determinants takes 
place in the context of RSCs and retinal progenitors. Future experiments addressing the identity of the 
protein binding to the Gli-motif (e.g., chromatin immunoprecipitation or electrophoretic mobility shift 
assays) will be required to determine whether these activating and repressing functions are mediated 
by one or more factors binding to the site identified. 
Given that our data indicates Gli TFs as activators in the CMZ, it is possible that the weak activity 
of the Sox2 mutant Rx2 CRE is mediated through the Gli-motif. This could be tested in a transgenic 
strain carrying an Rx2 reporter with both, altered Sox- and Gli-binding sites, and analyzing whether this 
results indeed in total loss of reporter expression in the CMZ. 
Based on the evidence collected, we propose a model for the confinement of post-embryonic RSCs to 
the peripheral post-embryonic CMZ, which incorporates the regulatory cues of transcriptional activators 
and repressors.
The Rx2-positive RSC population located within the CMZ is defined by both activators (Sox2, Tlx) and 
repressors (Gli3, Her9) (Figure 31), which have the ability to modulate stem cell features upon ectopic 
expression. Our data demonstrate that Sox2, similar to setting up neural competence in mammalian 
NSCs, induces Rx2 expression and stem cells fate in the CMZ (Figure 31A) and also ectopically. High 
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levels of the Her9 repressor in the central CMZ normally limit slow-cycling RSCs and consequently Rx2 
expression towards the differentiated central retina. On the peripheral side, Gli3 in its repressive form 
restricts Rx2 and prevents it from extending into the mitotically active domain of the adjacent RPE. Tlx, 
overlapping with Sox2 and in part Her9, specifies transiently amplifying neural precursors in the central 
part of the CMZ. The transcriptional confinement of Rx2 to the CMZ by the activity of the regulatory 
scaffold presented here (Figure 31B) connects the stem cells of the NR and those of the RPE and 
thus sheds light on the mechanism specifying this composite stem cell niche. We hypothesize that the 
combined activities of those factors within the Rx2 expression domain coordinate the proliferation and 
commitment towards neural lineages (either to the NR or the RPE) of the stem cells in the retina. 
Her9
Sox2
RPE CMZ
Rx2-positive
Retinal stem cells
Gli3
Tlx
A B
Figure 31. A proposed model summarizing spatial regulation of Rx2 expression and RSC-specific features 
by Sox2, Tlx, Gli3 and Her9.
(A) Schematic illustration outlining the spatial distribution of Rx2 (red), Sox2 (black dashed line), Tlx (green), 
Her9 (green) and Gli3 (blue) in the medaka CMZ and RPE. Magenta indicates overlap between red and blue; 
yellow indicates overlap between red and green.
(B) A model summarizing our findings on the regulation of multipotent Rx2-positive RSCs by Sox2, Tlx, Gli3 and 
Her9.
3.2 Expression of Rx2 might antagonize activity of the Shh pathway in 
the CMZ
Constitutive expression of Rx2 under the Atoh7 CRE did not alter proliferation in the stages analyzed. 
Rather, this approach resulted in a phenotype affecting the patterning of the RGC and INL. How this 
phenotype was established is presently unknown. Already before the phenotype was visible, Rx2-
expressing cells in the INL appeared in small clusters. One of the paralogs of Rx2, Rx3, has been 
shown to influence cell migration by transcriptionally antagonizing Nlcam expression (Brown et al. 
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2010). Molecules belonging to the Alcam family, which Nlcam is part of, have been shown to participate 
in cell-cell adhesion and to mediate cell migration (Heffron and Golden 2000). Ectopic expression 
of Rx2 might transcriptionally regulate the expression of cell adhesion molecules and encourage 
affected cells to form clusters. 4D imaging of the transgenic retinae could address whether this is an 
active process of Rx2-positive cells (labeled by RFP) migrating towards each other. Long-term in vivo 
imaging might also determine how the phenotype is established and whether only Rx2-expressing 
cells are involved.
In frog, injections of Rx mRNA have been shown to expand retinal tissues, resulting in the formation 
of folds and rosette-like structures within the layered retina (Wu et al. 2009). Although this phenotype, 
where multiple layers fold in parallel, differs from the one observed in the Atoh7::Rx2-T2A-mRFP 
retinae, both show defects in layering of the central NR. Consistent with our findings, Rx mis-expression 
did not induce ectopic proliferation (Wu et al. 2009). Conditional clonal gain-of-function assays based 
on the same tools used for Sox2, Tlx, Gli3 and Her9 will be necessary to address whether Rx2 itself is 
able to trigger stem cell features. Although the increased Rx2 levels coincided with reduced expression 
of molecular markers for RGCs, those experiments need to be quantified and compared to control 
retinae (e.g., Atoh7::mRFP). In studies in mouse and frog, it has been reported that Rx TFs regulate 
genes involved in photoreceptor specification (Pan et al. 2010; Muranishi et al. 2011). Morphologically, 
none of the Rx2-expressing cells resembled cones or rods in their shape; however, it still needs to be 
tested through expression profiling whether photoreceptor-specific genes are activated ectopically. 
Unlike Six3, which has been described to be involved in an auto-regulatory feedback-loop (Loosli et al. 
1999), gain of Rx2 did not activate ectopic Rx2 reporter expression (not shown). Similarly, transgenic 
reporters for Sox2, Tlx and Her9 were unaffected by Rx2 overexpression in the Atoh7 domain (not 
shown). This finding is consistent with the proposed role of Rx2 in our model as the RSC-specific 
component in the described regulatory scaffold, downstream of neural determinants. 
Surprisingly, expression controlled by the zebrafish Shh promoter was reduced in the GCL. The 
downregulation in Shh reporter expression is intriguing, since it indicates a possible cross-regulation 
between Rx2 and the Shh signal pathway. The relationship between Rx2 and the Shh CRE is presently 
unclear and needs to be addressed in detail. Computational analysis of the sequence of the Shh CRE 
could be used to predict putative Rx binding sites (Brown et al. 2010), which then could be modified to 
investigate the response in reporter expression. Future gene expression analyses of components of 
the Shh signal pathway, in particular the ligand itself and the Gli family members, in the Rx2 mutant will 
address whether loss of Rx2 achieves the opposite effect of Rx2 mis-expression, resulting in a more 
widespread secretion of Shh ligands and the expression of downstream mediators.
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It is tempting to speculate that endogenous Rx2 in RSCs prevents expression of the Shh ligand in the 
CMZ, thus, restricting broader expression of Gli genes and their transcriptional activity on target genes. 
Our data from in vitro and in vivo assays have shown that transcriptional regulators downstream of the 
Shh pathway regulate Rx2 expression; Rx2 is activated in the CMZ and prevented from expanding into 
the RPE, thus, confined to the peripheral CMZ. In turn, Gli TFs activating Rx2 could trigger a negative 
feedback loop, with Rx2 limiting the range of Shh signaling. In experiments carried out in Xenopus, 
it was demonstrated that balanced proliferation of retinal precursors depends on Hh and Wnt/beta-
catenin signaling pathways negatively regulating each other (Borday et al. 2012). Notably, expression 
Wnt ligands reduced transcriptional activity of the Rx2 CRE in the trans-regulation assays (not shown). 
Consistently, a previous study in mouse has linked Rx and canonical Wnt signaling by demonstrating 
that genetic inactivation of beta-catenin resulted in expanded expression of Rx at the expense of 
RPE-markers (Fujimura et al. 2009). Combining those results into a speculative model suggests that 
coordinated spatial interplay between Hh, Wnt and Rx is fine-tuning stem cell behavior and balancing 
their commitment towards either NR or RPE.
3.3 Rx mutants
3.3.1 TALEN pairs 106/107 and 128/129 produce disruptive mutations in Rx2
The data presented here demonstrate the success of targeted mutagenesis in medaka. By applying 
chimeric nucleases, we were able to induce stable, heritable genetic marks in specific sites of the 
endogenous Rx2 locus. Already transient expression of the TALEN pairs was sufficient to induce 
modifications in the genome of injected embryos. In zebrafish, the efficiency of TALEN mRNA injections 
has been described as potent enough to phenocopy morpholino-based knockdowns of previously 
described genes (Bedell et al. 2012). DNA fragments containing genetic alterations caused through 
erroneous NHEJ-mediated repair were detected in the band-retaining assay. Although this method has 
been used to determine the efficiency of targetable nucleases in injected embryos, we still identified 
false-positive sub-cloned fragments with an unchanged target site, underscoring the importance 
of confirmation through sequencing reaction. It has been suggested that TALEN mRNAs induce 
mutations in a dose-dependent manner (Ansai et al. 2013); whether increased mRNA concentration 
of the TALENs against Rx2 would decrease the occurrence of unmutated retained bands needs to 
be determined. Together with reports of biallelic changes in somatic cells in the injected zebrafish 
embryos (Bedell et al. 2012), this raises the possibility to study gene function by assessing phenotypes 
of the F0 generations. While the enzymatic restriction digest allows estimating mutagenesis activity, 
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mutations inside the target sequence not affecting the palindromic recognition sequence will not result 
in a retained band. Instead, the band will be digested and in the case of small insertions or deletions 
appear identical to cleaved wild-type bands, resulting in false-negatives. Interestingly, both pairs of 
TALENs created varying sizes of modifications in the respective genomic target sites, however, all 
of them were deletions. Other types of genetic modifications such as substitutions or insertions were 
absent from the sequenced clones. In both medaka and zebrafish, TALENs have been reported to 
produce mixtures of genomic changes through the homology-free repair pathway (Sander et al. 2011; 
Ansai et al. 2013). The bias towards deletions in our analyses could be explained through the relatively 
small sample size. For instance, for 128/129 TALEN-injected embryos only one clone (a mutant) was 
successfully sequenced. The target size of TALENs 106/107 is 19 base pairs in the Rx2 homeobox, 
while the recognition sequence of HpaII is 4 bases. For example, if insertions occur preferentially 
adjacent to the HpaII restriction site, the amplified DNA fragment will be cleaved and not sequenced. 
Thus, selecting a different restriction enzyme could lead ultimately to a different set of mutant carriers. 
However, the potential bias of the Rx2 TALENs to produce deletions did not present a disadvantage 
since the targetable nucleases were intended to induce disruptive lesions in exonic Rx2 sequences 
and produce mutants with frame-shifts or premature stop codons. The most promising F1 carriers 
revealed in the genotyping assays contained mutations in the centre of the homeobox in exon 2 of Rx2. 
While the majority were frame-shifts resulting in truncated proteins with only half of the homeodomain, 
one mutation removed two amino acids in the middle of the homeodomain. Whether the mutations 
do disrupt Rx2 protein function completely or create hypomorphic alleles needs to be determined 
by analyzing the phenotypic consequences in the homozygous progeny. Taken together, both Rx2 
TALENs efficiently induced heritable genetic modifications within the intended exonic regions and 
yielded mutant carriers for future functional studies.
3.3.2 Off-target activities of TALENs 106 and 107 can generate Rx1 mutants
Although the high binding specificity of TALENs has been demonstrated in a plethora of studies, 
unintended cleavages have to be taken into consideration. The most widespread method to assess 
off-target activity of TALENs is based on identifying and testing sequences in the genome similar to the 
binding site or target sites of choice. Several studies following this approach reported that off-target 
events accompanied cleavage in the desired genomic modifications at a low frequency (Hockemeyer 
et al. 2011; Mussolino et al. 2011; Tesson et al. 2011). Additionally, computational programs have been 
developed to improve genome-wide predictions of potential off-target sites (Grau et al. 2013). 
For the TALEN pair 106/107, which in contrast to pair 128/129 binds in the conserved homeobox, 
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off-target events were assessed in the paralogs of Rx2. The sites of potential off-target activity of the 
TALENs were determined by pair-wise alignment of the Rx1 coding sequence and binding domains 
of 106 and 107. The genotyping of the predicted Rx1 target site in F1 fish revealed the existence of 
TALEN-induced off-target deletions similar to those in the Rx2 homeobox. Since the F1 generation 
instead of the injected fish was tested, it is impossible to determine in which Rx gene TALENs 106 and 
107 preferentially induced DSBs. Interestingly, the genomic modifications in Rx1 were accompanied 
infrequently by additional deletions, which occurred always at the same position and affected the 
identical number of nucleotides. None of the sequencing reads for Rx2 were affected by similar 
unwanted modifications, arguing for this phenomena being linked to the TALEN-induced alterations in 
Rx1 locus, potentially due to the imperfectly binding TALEN 107, rather than general off-target events 
mediated by TALENs 106 and 107. All tested F1 fish with alterations in the Rx1 homeobox, both those 
with and without deletions upstream of the target site, were frame-shift mutants, resulting in shortened 
and partially incorrect Rx1 proteins. Thus, all the Rx1 mutants can still be tested for Rx1 loss-of-
function phenotypes. However, the molecular pathway causing these additional yet specific deletions 
upstream of the target site in Rx1 remains unknown. 
In general, we observed single nucleotide modifications at low frequency in individual sequencing 
reads with and without the desired genetic modifications during the genotyping, arguing for those 
mutations being introduced in the polymerase-based cloning process. Unidentified off-target mutations 
accompanying the desired modifications can be removed by consecutively crossing founders to wild-
type animals, provided that the unintended alterations are not closely linked to the desired mutation.
While off-target effects represent a serious problem, they open the opportunity to interrogate the 
function of similar genes with a limited number of TALENs. 
For instance, the promiscuity shown by TALENs designed against Rx2 could be exploited for in a small-
scale mutagenesis screen targeting genes similar to Rx, in particular those containing a homeobox. 
Not all Rx1 mutants identified in the F1 generation were carriers of Rx2 mutations and vice versa, 
arguing for independent instances of erroneous repair processes being the cause for the alterations in 
the individual Rx genes. Furthermore, the unintended deletions in Rx1 occurred in the predicted target 
site or in case of the additional off-target deletions, adjacent to it. Thus, alignments of the used TAL 
effectors with the protein-coding genes could be used as reference points    for the genotyping assays 
in such a mutagenesis screen.
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3.3.3 Phenotypic analysis suggests TALENs 106 and 107 might disrupt genes 
involved in early eye development 
The F1 of TALEN 106/107-injected fish, which crossed to heterozygous eyeless mutants, produced 
offspring in expected mendelian ratios without eyes, are likely to carry a mutation in the Rx3 locus. In 
that case it is reasonable to assume that these alterations occurred inside the homeobox of Rx3. Aligned 
with the sequence of Rx3, TALENs 106 and 107 produced two and four mismatches, respectively, 
flanked a window of 19 nucleotides. Through the sequencing of the Rx1 homeobox, it was confirmed 
that TALENs 106 and 107 have the ability to induce lesions, despite TALEN 107 containing three 
mismatches in the binding domain, giving in vivo evidence for the functionality of partially mismatching 
TAL effectors. An alternative explanation for the absence of eyes is presented by the possibility that 
these were transheterozygous mutants with one mutant Rx3 allele (from the eyeless carriers) and 
one mutated Rx1 or Rx2 allele (from the TALEN 106/107 F1). That the TALEN pair 106/107 has the 
potential to induce mutations in Rx1 or Rx2 has been confirmed by the genotyping done on injected 
fish. This theory could be tested by examining the offspring of a cross between the genotyped Rx1+/- or 
Rx2+/- mutants with heterozygous eyeless carriers. Consequently, transheterozygous progeny (Rx1+/- / 
Rx3+/- or Rx1+/- / Rx2+/-) should have the eyeless phenotype. However, Rx1 and Rx2 gene expression 
begins later than Rx3 expression, after the optic vesicles are established, arguing for the eyeless 
phenotype being caused by mutations in genes actively expressed during optic vesicle morphogenesis 
(e.g., Rx3). Ultimately, genotyping will be required to determine where the mutations contributing to the 
eyeless phenotype were introduced in the TALEN 106/107-injected fish.
3.3.4 The function of Rx2 remains unknown
Morpholino oligonucleotides directed against Rx1 and Rx2 did not yield any specific phenotypes. 
Morpholino-mediated knockdowns can be a powerful tool to inhibit gene function, however, since the 
morpholino oligonucleotides are delivered via microinjections at one-cell stage, they are designed to 
interfere with genes expressed during early embryogenesis. For instance, Rx3 morphants phenocopy 
the morphology of eyeless mutants and recover during later, when the morpholino nucleotides are 
diluted after multiple rounds of cell divisions, growing eyes identical in size to the uninjected siblings (L. 
Centanin and J. Wittbrodt, unpublished). As described above, Rx1 and Rx2 gene expression begins later 
than Rx3, arguing for a lack of phenotypes due to the inefficiency of the morpholinos during embryonic 
and adult stages when Rx1 and Rx2 might play a role. The knockdown of Rx1 and Rx2 transcripts was 
not evaluated through PCR or Northern analysis. While inefficient knockdown will not be a concern 
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in the Rx1 or Rx2 mutants, once these are crossed to homozygosity, there are a number of issues 
that could explain the lack of phenotype in the morphants, which might also concern the analyses of 
the mutants. Rx1 and Rx2 share similar expression domains and have related sequences, probably 
as a result of the teleost-specific genome duplication event, and therefore might have overlapping or 
partially redundant functions. As a consequence, disruption of a single Rx gene might result in no or 
subtle phenotypes only. The potential redundancy could be addressed by generating double-knockout 
mutants (Rx1-/- / Rx2-/-) by crossing the existing Rx1 and Rx2 carriers, preventing one Rx gene from 
compensating for the loss of the other one.
Systematic analysis of over 1200 zebrafish mutants revealed that less than 10% of the mutated genes 
caused a phenotype during development (Kettleborough et al. 2013). While redundancy of duplicated 
genes might contribute to the low percentage of phenotypes, other factors such as presence of 
maternal transcripts and loss-of-function phenotypes not resulting in external morphological changes 
have to be considered. Similarly, the phenotype of Rx1 or Rx2 mutants, even of the double-knockout 
mutants, could be very subtle compared to the dramatic phenotype of Rx3 mutants. Thus, phenotypic 
consequences caused by Rx1 or Rx2 loss-of-function might only be evident in assays providing single-
cell resolution, such as transplantation experiments, where labeled mutant cells are transplanted to 
wild-type host and vice versa at blastula stage. 
Interestingly, during the incrossing of TALEN-injected F0 fish, where we identified the embryos 
resembling eyeless mutants, we also observed the occurrence of embryos with small eyes, although not 
in mendelian ratios. The phenotype became apparent at optic cup stage and while the eyes continued 
to grow in size, they were smaller than those of phenotypically normal siblings or stage-matched 
wild-type embryos (not shown). These mutant embryos were grown to adulthood without genotyping 
and will be incrossed to test whether the progeny are affected by similar anatomical abnormalities. It 
is tempting to speculate about the connection between the functions of Rx genes and altered mitotic 
activity of retinal progenitors being the cause for small optic cups in the mutant embryos.
Rx genes are molecular markers of quiescent stem cells in the post-embryonic amphibian retina - Rx2 
labels RSCs in the peripheral CMZ and Rx genes are expressed in the MGCs located the central NR. 
If Rx genes indeed play a functional role in maintaining multipotent stem cells in a quiescent state, loss 
of Rx could result in increased short-term proliferation in the CMZ, depleting the pool self-renewing 
cells, which would interfere with the steady supply of new neurons required for the constant growth of 
the fish retina. Small-eyed zebrafish mutants with an enlarged CMZ containing very few proliferative 
active cells have previously been reported (Wehman et al. 2005). In case of a similarly enlarged CMZ 
in the TALEN-induced small eye mutants, this would argue for Rx being required for restricting the 
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population of quiescent cells in the CMZ and potentially interfering transciptionally with their cell cycle 
progression. However, so far the correlation between phenotype and genotype, as well as shape of the 
CMZ, if any exists, is unknown.
Complementary to the analyses of the morphological consequence, the regulatory network orchestrated 
by Rx genes could be delineated in the stable mutants. Gene expression profiling of the Rx mutants 
through transcriptome assembly from RNA deep sequencing data would give insight into the biological 
processes and genetic programs Rx2 is involved in. Chromatin immunoprecipitation followed by 
microarray analysis or deep sequencing could predict the direct targets forming the transcriptional 
network downstream of Rx2. For this purpose, tagged Rx2 fusion proteins, which exist in the laboratory 
(D. Inoue and J. Wittbrodt, unpublished), will be inserted as transgenes in the genome of the Rx2 
mutants. The expressed fusion protein would then allow the immunoprecipitation with commercial 
antibodies for the genome wide mapping of Rx2 bindings sites.
3.3.5 Applications of nuclease-based genome editing in fish
The findings that TALEN-induced stable genetic marks in medaka are feasible raises the possibility 
to carry out more advanced nuclease-induced genetic engineering in the fish model. While the type 
of mutation generated by incorrect NHEJ is unpredictable, the majority is likely to cause frame-shifts 
through small indels. On the other hand, homology directed repair offers precise control over genetic 
editing and opens the opportunity to a variety of different applications. By simultaneously providing a 
DNA donor with homology flanks matching the target region and locus-specific nucleases, the type 
and position of modification can be freely orchestrated with single-nucleotide resolution. Insertions of 
up to 8000 base pairs have been reported (Moehle et al. 2007). Experiments carried out in ESCs and 
IPSCs provided evidence for the efficiency and precision of genome editing with TALENs being similar 
to ZFNs (Hockemeyer et al. 2011). TALEN-mediated genome editing has already been successfully 
utilized to insert a lox-site in the zebrafish genome, which presents a crucial step to carry out advanced 
genetic studies of conditional alleles in fish (Bedell et al. 2012). In particular, TALEN-mediated homology 
directed repair to generate functional fusion proteins in vivo without being disruptive is desirable and 
will be beneficial for a wide range of applications. As it has been demonstrated for the endogenous Oct4 
locus in ESCs, nuclease-mediated integration of a splice acceptor-EGFP into an intron or replacement 
of the stop codon can yield in frame fusion proteins expressed in physiological levels (Hockemeyer 
et al. 2011). Due to their accurate spatio-temporal expression, transgenic reporter lines generated in 
this manner could one day replace traditional expression reporter designs based on recombined BACs 
or isolated regulatory elements. Although improved protocols allow immunohistochemistry in medaka 
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and zebrafish based on antibodies against conserved proteins from other species (Inoue and Wittbrodt 
2011), the lack of fish-specific antibodies has been a long-standing problem. Proteins fused either 
with a fluorescent protein or a small exogenous tag will be a valuable resource in particular for studies 
requiring specific antibodies, such as cell-type specific immunoprecipitations or protein-localization 
studies. 
Using targeted nucleases to generate loss-of-function mutants and tag the gene of interest provides a 
powerful resource to study direct downstream targets. Similar to what has recently been demonstrated 
with RNA-guided nucleases in transgenic GFP-expressing zebrafish, where the GFP coding sequence 
was replaced with RFP (Auer et al. 2013), existing tissue-specific fluorescent reporter strains caused 
through positional effects could be exploited by exchanging the existing reporter cassettes with Cre or 
Flp coding sequences supplied by the donor DNA. 
 
3.4   Outlook
By investigating the regulatory input on the Rx2, the molecular marker for multipotent RSCs, we 
identified a regulatory framework defining the stem cell compartment of the post-embryonic NR, 
the CMZ. However, many aspects have to be addressed in detail to fully understand the definitive 
mechanisms underlying this regulatory network. 
The potential of undifferentiated cells in the RPE is poorly understood. Studying the composition of 
clones originating from individual Gli3-positive cells will address whether these cells are stem cells or 
progenitors with a limited capacity to self-renew. Particularly, lineage-tracing of the cells co-expressing 
Rx2 and Gli3 in the CMZ will delineate the contribution of the stem cells of the NR and those of the 
RPE; thus, shed light on the mechanism coordinating those adjacent stem cell domains. Making use 
of the rapidly evolving methods allowing targeted genome modifications, conditional clonal loss of 
Sox2, Tlx, Gli3 or Her9 will give insight into the molecular mechanism governing multipotency and 
mitotic activity in RSCs. Examining the outcome of sustained clonal expression of Tlx or Her9 in the 
peripheral Rx2-domain will help us to understand how the commitment of individual RSCs to the NR or 
the RPE is regulated. Analyzing the behavior of RSCs in the TALEN-induced Rx2 mutants will address 
the functional role Rx2 in the regulatory scaffold. In particular investigating the progeny of individual 
mutant stem cells will reveal whether Rx2 coordinates stemness in both the NR and the RPE. 
    
  MATERIALS AND METHODS
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4 Materials and Methods
4.1 Materials
4.1.1 Buffers
All buffers not specifically described in this section were prepared according to standard protocols 
(Sambrook et al. 1989) using highly deionized water (Millipore), unless indicated differently. Sterilization 
was achieved by autoclaving.
6x DNA loading buffer
ficoll (type 400, Pharmacia) 15 % (w/v)
bromphenol blue 0.05 % (w/v)
xylene cyanol FF 0.05 % (w/v)
Embryonic Rearing Medium (ERM)
NaCl (Merck) 0.1 % (w/v)
KCl (Merck) 0.003 % (w/v)
CaCl2 × 2H2O (Merck) 0.004 % (w/v)
MgSO4 × 7H2O (Merck) 0.016 % (w/v)
Fin clip buffer
Tris (Sigma)-HCl (Merck), pH8.0 400 mM
EDTA (Merck), pH8.0 5 mM
NaCl 150 mM
SDS 0.1 % (v/v)
LB agar
Agar 15 g/l in LB medium
dissolved by boiling
LB medium (Luria-Bertani)
tryptone 10 g/l
yeast extract 1 g/l
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NaCl 10 g/l
to pH7.0 with 5N NaOH (Merck), autoclaved
Hatching medium
NaCl (Merck) 0.1 % (w/v)
KCl (Merck) 0.003 % (w/v)
CaCl2 × 2H2O (Merck) 0.004 % (w/v)
MgSO4 × 7H2O (Merck) 0.016 % (w/v)
Methylene blue 0.0002 % (w/v)
PBS
NaCl 10 mM 
KCl (Merck) 195 mM
Na2HPO4 (Merck) 5.9 mM
KH2PO4 (Merck) 1.1 mM 
pH adjusted to 7.3
PTW
PBS containing 0.1 % Tween 20
TAE buffer
Tris 40 mM
acetic acid (Merck) 20 mM
EDTA 1 mM
TE buffer
Tris-HCl, pH8.0 10 mM
EDTA, pH8.0 1 mM
4.1.2 Oryzias latipes stocks
Wild-type Oryzias latipes from a closed stock at the COS were kept as described (Koster et al. 1997). 
Transgenic lines Rx2::H2B-mRFP (Inoue and Wittbrodt 2011), Rx2::Tub-GFP (generated by Juan-
Ramon Martinez-Morales) Atoh7::mYFP (Filippo Del Bene) and Shh::GFP (generated by Beate 
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Wittbrodt) were used in this study. The eyeless mutants were kept as described (Winkler et al. 2000; 
Loosli et al. 2001). 
4.1.3 Laboratory equipment and instruments
Binoculars and Stereo Microscopes
DM5000 scope (Leica) with a DFC500 camera (Leica)
Stemi 2000-C (Zeiss)
Stemi SV 11 (Zeiss)
Centrifuges
5417 C (Eppendorf) 
5430 R (Eppendorf) 
5810 R (Eppendorf) 
Cryostat 
CM3050S (Leica)
Electroporator
Micro Pulser electroporator (Bio-Rad)
Fluorescence binoculars
Olympus MVX10 MacroView (Olympus)
Incubators
Hera CO2 cell incubator 150 (Heraus)
Hybaid OmniGene (MWG-Biotech)
Innova 44 Incubator Shakers (New Brunswick Scientific)
Rumed (Rubarth Apparate)
Laminar flow hood 
Hera safe HS12 (Heraus)
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Laser scanning confocal microscope
(Inverted) TCS SPE (Leica) 
Luminescence Counter 
Victor Light 1420 (PerkinElmer)
Microinjector
InjectMan NI 2 (Eppendorf)
Microinjector 5242 (Eppendorf) 
Nanodrop
Nanodrop Spektrophotometer ND-1000 (peqlab Biotechnologie)
Thermocycler
PTC-200 Peltier Thermal Cycle (Bio-Rad)
Thermomixer
Thermomixer compact (Eppendorf)
4.1.4 Reagents 
Alkaline Phosphatase (Roche)
dNTP Mixture, 2.5mM each (Takara)
Fast Red Tablets (Roche)
GeneRuler Ladder Mix (Fermentas) 
House Taq Polymerase (EMBL)
innuPREP Gel Extraction kit (Analytik Jena)
innuPREP PCRpure kit (Analytik Jena)
Klenow (Roche)
Ligation buffer (Fermentas)
mMessage machine (SP6) kit (Ambion)
Pfu DNA Polymerases (Stratagene)
Phusion® DNA Polymerase (Thermo Scientific)
QIAfilter Plasmid Maxi kit (Qiagen)
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QIAquick Gel Extraction kit (Qiagen)
QiaQuick Nucleotide Removal kit (Qiagen)
QuikChange™ Site-Directed Mutagenesis Kit (Stratagene)
Restriction enzyme buffer (Fermentas, Roche, New England Biolabs)
Restriction enzymes (Fermentas, Roche, New England Biolabs)
RNA Polymerase (SP6, T7) (Roche)
RNeasy Mini kit (Qiagen)
T4 DNA ligase (Fermentas)
TSA™ Plus Fluorescein System (PerkinElmer)
4.1.5 Miscellaneous Materials
Agarose (Sigma)
GC100F-10 Borosilicate glass capillaries with filament (Clark Electromedical Instruments)
4.1.6 Chemicals 
5-bromo-4-chloro-3-indolyl-phosphate (Roche)
Aceton (Sigma)
Anti-Digoxigenin-AP, Fab fragments (Roche)
Anti-Fluorescein-POD, Fab fragments (Roche)
Blocking reagent (Roche)
Cover slips (24 mm x 60 mm) (Roth)
DAPI (Sigma)
Digoxigenin-UTP (Roche)
Fast Red Tablets (Roche)
Fluorescein-UTP (Roche)
Formamide (Sigma)
Glass Bottom Culture Dishes (35mm) (MatTek)
Glycerol (Merck)
Glycin (Merck)
Heparin sodium salt (Sigma)
Methanol (Merck)
Nitro blue tetrazolium chloride (Roche)
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Proteinase K, 20mg/ml (Roche)
Ribonucleic acid from torula yeast, type VI (Sigma)
SeaPlaque GTG agarose (FMC BioProducts) 
Sheep serum (Sigma)
Sodium citrate (Sigma)
Sucrose (Sigma)
Superfrost Plus (Thermo Scientific)
Tissue Freezing Medium (Jung)
TSA™ Plus Fluorescein System (PerkinElmer)
Tween 20 (Sigma)
4.1.7 Cell culture and DNA plasmid transfection
Dishes Nunclon (Nunc)
DMSO (Merck)
Dual-Luciferase Reporter Assay System (Promega)
Dulbecco’s Modified Eagle Medium (1x), liquid (High Glucose), 4500 mg/l D-Glucose, without Sodium 
Pyruvate and L-Glutamine (Invitrogen)
Foetal Bovine Serum, Qualified, Heat-Inactivated (Invitrogen)
FuGENE6 Transfection Reagent, (Roche)
L-Glutamine 200 mM (100x), liquid (Invitrogen)
Opti-MEM® I Reduced Serum Medium (1X), liquid - with L-Glutamine (Invitrogen)
OptiPlate-96, White Opaque 96-well Microplate, (PerkinElmer)
Penicillin-Streptomycin-Glutamine (100x), liquid (Invitrogen)
Stericup-GP, 0.22 um (Millipore)
Trypsin-EDTA Solution (1x) (Sigma)
4.1.8 Antibodies
Primary antibodies
chicken anti-GFP (1:500, Invitrogen)
mouse anti-PCNA (1:100; Santa Cruz)
mouse anti-BrdU (1:50, Becton Dickinson)
mouse anti-Islet (1:250, DSHB)
82
Materials and Methods
mouse anti-Zpr1 (1:250, ZIRC)
mouse anti-GS (1:50, Chemicon)
rabbit anti-Phospho-Histone3 (1:500; Upstate)
rabbit anti-OlRx2 (1:500)
rabbit anti-DsRed  (1:250, Clontech)
Secondary antibodies
anti-chicken (1:500, DyLight488, DyLight549 and DyLight647, Jackson)
anti-mouse (1:500, DyLight488, DyLight549 and DyLight647, Jackson)
anti-rabbit (1:500, DyLight488, DyLight549 and DyLight647, Jackson)
4.1.9 Cell line
Syrian Hamster Fibroblast (BHK21)
4.1.10 Electrocompetent cells
Electro MAX DH10B cells (Stratagene)
4.1.11 Embryo injection plates
Petri dishes were filled with liquid 1.5 % (w/v) agarose (Sigma) in H2O. Afterwards, plastic molds were 
added to create the injection trenches during agarose solidification.
4.1.12 TALEN
The TALENs designed to bind the Rx2 coding sequence were provide by (Jean-Paul Concordet) in 
pCS2+ backbones with the following DNA binding domains: N106: TCGAGAAGTCCCACTA; N107: 
TCGTTGCCAGTTCCTC; S128: TCAGAACCCTATGGAA; S129: GATGCTGTGAGCTGTC.
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4.2 Methods
4.2.1 Generation of medaka unigene cDNA library
Full-length cDNA clones were generated based on total RNA extracted from medaka embryos of 
different developmental stages as previously described (Souren et al. 2009). The cDNAs were inserted 
into a pCMVSport6.1 vector, end-sequenced, clustered based on sequence alignments and collected 
in a consolidated unigene library. Based on GO annotations a subset of developmental relevant genes 
and genes encoding TFs were collected in a library consisting of 1151 cDNA clones (Thorsten Henrich).
4.2.2 Molecular cloning
A cassette containing the LexOP operator upstream of the Cherry coding sequence was extracted 
from pDs(cry:C-LOP:Ch). The Cherry coding sequence was replaced with H2B-EGFP and H2A-
Cherry. Effectors: LexOP::H2A-Cherry; LexOP::H2B-EGFP; LexOP::Cherry. A cassette containing 
the coding sequence for the LexPR trans-activator followed by the LexOP operator was released 
from pDs(krt8:LPR-LOP:G4) and inserted downstream of the Rx2 CRE (Inoue and Wittbrodt 2011). 
Coding sequences for Gli3 and Her9 were inserted downstream of the LexOP operator. A second 
LexOP operator followed by H2B-EGFP coding sequence was added (released from LexOP::H2B-
EGFP). Driver-Effectors: Rx2::LexPR LexOP::Gli3 LexOP::H2B-EGFP; Rx2::LexPR LexOP::Her9 
LexOP::H2B-EGFP; Rx2::LexPR LexOP LexOP::H2B-EGFP.
A cassette containing the coding sequence for the LexPR trans-activator followed by the LexOP 
operator was introduced downstream of the cska promoter (Grabher et al. 2003). Coding sequences for 
Sox2 and Tlx were inserted downstream of the LexOP operator. Drivers: Cska::LexPR LexOP::Sox2; 
Cska::LexPR LexOP::Tlx,; Cska::LexPR LexOP.
LexPR and LexOP cassettes were derived from pDs(krt8:LPR-LOP:G4) and pDs(cry:C-LOP:Ch) to 
generate driver, effector or driver-effector constructs (Emelyanov and Parinov 2008). The 2.4 kb Rx2 
CRE was released through restriction digest and cloned upstream of the luciferase gene in to the pGL3 
luciferase reporter vector (Promega).
Coding sequences for Sox2, Gli3 and Her9 were derived from a full-length cDNA library based 
on the pCMV-Sport6.1 vector (Souren et al. 2009), Tlx cDNA was derived from a Lambda 
ZAP cloning vector (Felix Loosli). Full-length OlRx2 coding sequence (NP_001098373.1) for 
antibody generation was cloned by PCR from medaka stage 32 cDNA using the following 
primers: forward primer: 5’-GGAATTCCATATGATGCATTTGTCAATGGATAC-3’; reverse primer: 
5’-CGGGATCCTCACATGTGCTGCCAGG-3’. PCR products were digested with restriction enzymes 
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NdeI and BamHI, ligated into the pET15b (Merck Millipore), which was cleaved with the same enzymes. 
pET15b-OlRx2 was used to bacterially express OlRx2 protein as the antigen for generation of OlRx2 
antibody (Daigo Inoue). All constructs generated for transient expression or transgenesis were based 
on a pBluescript plasmid containing two I-SceI sites flanking the insert.
The gene regulatory regions of Tlx, Sox2 and Her9 were amplified via PCR from 
genomic DNA using the following primers for Tlx (ENSORLG00000013426): forward 
primer: 5’-GGCGGAATATTTAATGAACTGTAGATACGTTGATCA-3’; reverse primer: 
5’-CTCACACGGCAGTGACGTAAGG-3’; Sox2 (ENSORLG00000011685): forward primer: 
5’-TTTACAAGTGGTCCGAGGGAG-3’; reverse primer: 5’-CAGGGAAAATTTTAACTTTTCGCTGGG-3’; 
and Her9 (ENSORLG00000005453): forward primer: 5’-AGCGCTTCATTAGTGTGGGCG-3’; reverse 
primer: 5’-GCGCACAGCAGCTCTCCACA-3’. The corresponding PCR products were cloned into a 
pBluescript-based transgenesis vector containing two recognition sites for the meganuclease I-SceI 
(New England Biolabs) flanking a multiple cloning site followed by a cassette containing an enhanced 
GFP and a SV40-polyadenylation signal.  
Fusion PCR
The Rx2 coding sequence was amplified excluding the last three nucleotides (stop codon) from Rx2 
cDNA with the following primers:
Rx2 forward primer: 5’-ATGCATTTGTCAATGGATACCC-3’; reverse primer: 
5’-AGGGCCGGGATTCTCCTCCACGTCACCGCATGTTAGAAGACTTCCTCTGCCCTCTCCCATGT-
GCTGCCAG-3’, underlined overhangs encode T2A (Kim et al. 2011). In a separate PCR the mRFP 
coding sequence was obtained from the linearized Vsx3::H2B-mRFP (Marcel Souren) vector with the 
following primers: forward primer: 5’-GAGGGCAGAGGAAGTCTTCTAACATGCGGTGACGTGGAGG-
AGAATCCCGGCCCTATGGCCTCCTCCGAGG-3’, underlined overhangs encode T2A; reverse primer: 
5’-AACAAAAGCTGGAGCTCCA-3’.  A single fusion PCR was performed on the resulting PCR products 
with the Rx2 forward primer and mRFP reverse primer. Afterwards, the Rx2-T2A-mRFP fragment was 
cut with NotI (recognition site in mRFP reverse primer not shown) and ligated into Atoh7::mYFP (Filippo 
Del Bene), which was digested with SnaBI and NotI to release the mYFP and provide a complementary 
overhang. All PCR fragments were amplified with identical PCR steps (30 sec 98°C, (20 sec 98°C, 45 
sec 60°C, 1 min 15 sec 72°C) repeated for 4 cycles, (20 sec 98°C, 45 sec 58°C, 1 min 15 sec 72°C) 
repeated for 9 cycles, (20 sec 98°C, 45 sec 56°C, 1 min 15 sec 72°C) repeated for 14 cycles, followed 
by 72°C 5 min) and purified with the innuPREP Gel Extraction kit (Analytik Jena) or the innuPREP 
PCRpure kit according to manufacturers protocol.
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Site-directed mutagenesis
Amino-acid substitutions or deletions were introduced into the Rx2 gene regulatory region of Rx2::H2B-
mRFP by site-directed mutagenesis (3 min 95°C, (30 sec 95°C, 30 sec 55°C, 12 min 30 sec 72°C) 
repeated for 18 cycles, followed by 15 min 72°C) using the following primers: Sox-binding site, forward 
primer: 5’-CCACACAAGCCATTATCTTTCAGACGCTAGATTTGTTGAAAGGAAGTTTTGT-3’; reverse 
primer: 5’-ACAAAACTTCCTTTCAACAAATCTAGCGTCTGAAAGATAATGGCTTGTGTGG-3’;
Gli-binding site, forward primer: 
5’-GAAGTTTTGTTGAGGCTTCATTAGCAATGTGGTCTGAAAGCAG-3’; reverse primer: 
5’-CTGCTTTCAGACCACATTGCTAATGAAGCCTCAACAAAACTTC-3’. 
All steps were carried out according to the manufactures protocol (QuikChange™, Stratagene) with 
the exception of the transformation, which was done using electrocompetent DH10B cells.
mRNA transcription in vitro
Supercoiled DNA of the pCS2+ plasmid was subjected to restriction digest with NotI and the linearized 
DNA template was purified using the innuPREP PCRpure kit (Analytik Jena) according to the 
manufacturers protocol. TALEN N106, N107, S128 and S129 mRNA transcription in vitro from the 
SP6 promoter was performed using the mMessage machine (Ambion) according to the manufacturers 
protocol. The mRNA was purified using the RNeasy RNA purification kit (Qiagen) according to the 
manufacturers protocol and stored at –80°C.
4.2.3 Microinjection
Fertilized eggs were collected from wild-type CAB or transgenic crosses and placed in chilled ddH2O to 
slow down development. For microinjections a pressure injector was used. Borosilicate glass capillaries 
(Clark Electromedical Instruments) were backfilled with the injection solution (final concentration DNA: 
30 ng/ul). The injection solution was injected through the chorion into the cytoplasm of the one-cell 
stage embryos. TALEN mRNAs (N106 and N107; S128 and S129) were co-injected at a concentration 
of up to 100 ng/ul in ddH2O. For transient mosaic expression injection solution (DNA) was injected into 
the cytoplasm at two-cell stage.
4.2.4 Generation of transgenic lines
Transgenic lines were established by co-injection of the DNA plasmid and I-SceI enzyme into one-
cell stage medaka eggs as described (Thermes et al. 2002). All DNA plasmids used in injections 
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were isolated from bacterial lysate using Qiagen-tip 500 columns from the QIAfilter Plasmid Maxi kit 
(Qiagen) according to manufacturers protocol.
4.2.5 BrdU treatment
Embryos were incubated in a solution of 1 g/l BrdU for a varying amount of time and fixed immediately 
afterwards in 4 % PFA/PTW.
4.2.6 RU486 treatment
Mifepristone (Sigma, Tocris, Cayman) was dissolved in DMSO to a final concentration of 25 mM and 
stored as stock solution at -20 °C. The stock solution was added to the medium and used at final 
concentrations up to 20 uM.
4.2.7 pBluescript-TA
A PCR under low-stringency conditions (5 min 95°C, (45s 95°C, 45s 45°C, 1 min 72°C) repeated 
for 29 cycles, followed by 5 min 72°C) using a single primer (CGGAATTCCCATGGTTGTGATGGG, 
recognition site for EcoRI underlined, XcmI bold) on medaka CAB genomic DNA yielded random 
fragments of various sizes after standard gel electrophoresis (Beate Wittbrodt). A 500 bp fragment 
was excised from an agarose gel using the innuPREP Gel Extraction kit according the manufacturers 
protocol (Analytik Jena). Taq DNA polymerase derived A-overhangs were used to sub-clone the PCR 
fragment into the pCR®II-TOPO® vector provided by the TOPO® TA Cloning® Kit (Invitrogen) according 
the manufacturers protocol. The inserted fragment, which retained EcoRI recognition sequences in its 
flanks from the oligonucleotide, was released from pCR®II-TOPO® vector through enzymatic digest 
with EcoRI and ligated into an EcoRI-cleaved pBluescript II vector. After restriction digest with XcmI, 
the 500 bp insert was released from the linearized vector, leaving behind T-overhangs flanked by 
EcoRI recognition sequences. The fragments were separated by standard gel electrophoresis, the 
linearized pBluescript-TA vector was excised, purified and stored at -80°C. PCR fragments intended 
for TA cloning were always freshly prepared. The two EcoRI sites of the pBluescript-TA vector allow 
rapid identification of clones, which successfully inserted the DNA fragment of interest.
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4.2.8 Genotyping
4.2.8.1 Genomic DNA extraction
Single medaka eggs were placed in individual 2 ml tubes, flash-frozen in liquid nitrogen, crushed with 
sterile pestle and homogenized in 100 μl (for pool of embryos use 300 ul) fin clip buffer containing 
proteinase K (add 500 μl proteinase K (20 mg/ml) to 10 ml fin clip buffer) (Beate Wittbrodt). The 
homogenate was incubated o/n at 60 °C. Afterwards 200 μl ddH2O (500 μl for multiple embryos) were 
added and the tube gently turned without shaking and incubated for 10 min at 95°C. After a short spin 
down of the samples, the supernatant was transferred to a fresh tube and stored at 4°C. 
For the isolation of genomic DNA from adult tissues, fish were transferred into ice water or 0.4 % 
Tricaine (4 ml Tricaine in 100 ml fish water), collected with a large plastic spoon and cut at the tailfin. 
The tissue samples were placed with the aid of forceps in tubes and 100 μl fin clip buffer containing 
proteinase K was added. The adult fish were kept in 2/3 hatching medium and 1/3 fish water o/n. The 
remaining steps of the genomic DNA extraction from adults were carried out as described above.
4.2.8.2 Genotyping PCR and restriction digest-based band-retention 
The regions of interest for TALEN pair 106/107 were amplified from the isolated genomic DNA with 
the following primers: Rx1 forward primer: 5’-ATTCGTCCGTGTGGACCTGT-3’; reverse primer: 
5’-TCTCGTCCTCCAAACAGACA-3’; Rx2 forward primer: 5’-AACAGTGAGTAGCGGGTCGT-3’; 
reverse primer: 5’-TCTGAGGGATGGAATTCTGG-3’. The PCR amplification was mediated by a 
proofreading polymerase (Rx1: 30s 98°C, (20s 98°C, 45s 67°C, 15s 72°C) repeated for 29 cycles, 
followed by 5 min 72°C; Rx2: 30s 98°C, (20s 98°C, 45s 67°C, 45s 72°C) repeated for 29 cycles, 5 min 
followed by 72°C) and followed by 15 min at 72°C with Taq polymerase. The resulting PCR products (Rx1: 
300 bp; Rx2: 930 bp) were enzymatically digested with HpaII for 1 h. The region of interest for TALEN 
pair 128/129 was amplified from the isolated genomic DNA with the following primers: Rx2 forward 
primer: 5’-GAGTCCAAAGGCAAGTCCAC-3’; reverse primer: 5’-TTTGAACCTCTCGCTGTGA-3’. The 
PCR amplification was mediated by a proofreading polymerase (Rx2: 30s 98°C, (20s 98°C, 45s 67°C, 
45s 72°C) repeated for 29 cycles, 5 min followed by 72°C) and followed by 15 min at 72°C with Taq 
polymerase. The resulting PCR products (1040 bp) were enzymatically digested with BspEI for 1 h. 
The uncleaved bands retaining original size were purified and through the Taq polymerase derived 
A-overhangs ligated into a pBluescript-TA vector, with complementary T-overhangs created by the 
restriction enzyme XcmI. The DNA minipreps were subjected to restriction digest with EcoRI and 
clones with the correct insert size were selected for sequencing.
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4.2.9 WISH
4.2.9.1 Riboprobe preparation
For anti-sense riboprobe synthesis linear templates were produced from full-length cDNA clones either 
through standard PCR using standard M13 forward and reverse primers (Sox2, Gli3 and Her9) or 
digestion with restriction enzymes cutting 5’ of the start codon (Rx2 and Tlx). T7 RNA polymerase-
based transcription and incorporation of digoxigenin-UTP or fluorescein-UTP was carried out as 
previously described (Loosli et al. 1998). 
4.2.9.2 Single color WISH
Whole-mount in situ hybridizations using NBT/BCIP detection were carried out as previously described 
(Loosli et al. 1998).
4.2.9.3 (Double-) Fluorescent WISH
Fluorescent whole mount in situ hybridizations were performed as previously described (Souren et al. 
2009). For combined single-color fluorescent whole mount in situ hybridization and immunostaining, 
embryos were incubated for two days with anti-fluorescein antibody conjugated to horseradish 
peroxidase (Roche) and anti-GFP antibody at 4°C. After riboprobe detection using TSA-Plus Cyanine 
3 System (PerkinElmer) the embryos were incubated with fluorescent-conjugated secondary antibody 
and DAPI for two days at 4°C. In case of WISH followed by immunostaining, the embryos were 
subjected to 3 % H2O2 (Sigma), 1 % KOH in 1x PTW for 30 minutes at RT after fixation and removal 
of the chorion.
4.2.10 Immunohistochemistry
4.2.10.1 Rx2 antibody 
Anti-OlRx2 antibody was raised against the full-length OlRx2 (NP_001098373.1) recombinant protein 
in rabbits (Charles River), and affinity purified as described previously (Barenz et al. 2013).
4.2.10.2 Fixation
Embryos were fixed in 4 % PFA/PTW o/n at 4°C.
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4.2.10.3 Antigen retrieval and cryosections
Fixed embryos were washed in PTW. In case of embryos fixed at pre-hatch stages, the chorion 
was removed with forceps. Cryoprotection, heating steps for retrieving antigens and sections were 
performed as previously described (Inoue and Wittbrodt 2011).
4.2.10.4 Immunostaining on cryosections
Dried cryosections were incubated in aceton for 10 min at -20°C. When necessary, cryosections were 
subjected to 3 % H2O2 (Sigma), 1 % KOH in 1x PTW for 30 minutes at RT prior to the aceton step. The 
sections were washed and blocked with 10 % sheep serum/PTW for at least 2 h at RT. Afterwards, 
incubation with the primary antibody followed o/n at 4°C. The cryosections were washed and incubated 
with the secondary antibody for 90 min at 37°C in the dark. Cell nuclei were counterstained with DAPI 
(final concentration; 200 mg/ml) for 5 min at RT in the dark. For imaging, the slides were washed, 70 % 
glycerol and was added. The stained tissues were covered with cover slips and sealed with nail polish. 
All washing steps were performed with 1x PTW for 10 min for at least three times.
For BrdU detection, cryosections were dried o/n, re-hydrated with 1x PTW and treated with 2N HCL, 
0.5 % Triton X-100 in 1x PBS for 90 minutes at RT.
4.2.11 Imaging
Images of sections and whole-mount embryos were acquired using the Leica Application Suite 
Advanced Fluorescence software and an inverted Leica TCS SPE confocal microscope with ACS APO 
10x/0.30, 20x/0.60, 40x/1.15 and 63x/1.30 objective lenses. 405 nm, 488 nm, 532 nm and 635 nm 
laser lines were used for fluorophore excitation. Whole-mount embryos were mounted as previously 
described (Ramialison et al. 2012). Images were processed using ImageJ software, v.1.41o. Images of 
NBT/BCIP stainings were taken using a Leica DM5000 scope equipped with a Leica DFC500 camera. 
4.2.12 Trans-regulation screen
Cell culture, transfection and luciferase read-out were carried out with 1151 cDNA clones (300 ng) on 
the pGL3 Rx2::luc2 vector (40 ng) as previously described (Souren et al. 2009).
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Abbreviations
AC   amacrine cell
Atoh7   atonal homolog 7
Bmp   Bone morphogenetic protein
BPC   bipolar cell
BrdU   bromodeoxyuridine
Cas   CRISPR-associated 
cDNA   complementary DNA
CMV   cytomegalovirus
CMZ   ciliary marginal zone
CRE   cis-regulatory element
CRISPR  Clustered, regularly interspaced, short palindromic repeats 
DAPI   4’, 6-diamidino-2-phenylindole
DMSO  Dimethylsulfoxide
DNA   deoxyribonucleic acid
EMS   ethyl methanesulfonate 
ENU   N-ethyl-N-nitrosourea
Fgf   fibroblast growth factor
GCL  ganglion cell layer
GFP   green fluorescent protein
H2A   histone 2A
H2B   histone 2B
HC   horizontal cell
Hh   hedgehog
IGF   insulin-like growth factor
INL   inner nuclear layer
IPL   inner plexiform layer
MGC   Muller glia cell
mRFP   monomeric red fluorescent protein
mRNA   messenger RNA
NHEJ   non-homologous end-joining
NR   neural retina
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NSC  neural stem cell
O.l.   Oryzias latipes
o/n   overnight
ONL   outer nuclear layer
OPL   outer plexiform layer
Pax   Paired box
PBS   Phosphate Buffered Saline
PCR   polymerase chain reaction
PFA   paraformaldehyde
PTW   PBS with Tween20
Rax/Rx  Retinal homeobox
RGC   retinal ganglion cell
RNA   ribonucleic acid
RPC  retinal progenitor cell
RPE   retinal pigmented epithelium
RSC  retinal stem cell 
RT   room temperature
SDS   sodium dodecyl sulfate
Shh   sonic hedgehog
Six   sine oculis homeobox homologue
Sox   Sex determining Y-box-related high-mobility group box
TALEN  Transcription activator-like effector nuclease
TF   transcription factor
TFBS   transcription factor binding site
TILLING  targeting induced local lesions in genomes
TRS  trans-regulation screen 
WISH   whole mount in situ hybridization
Wnt   wingless and int-1
ZFN   zinc-finger nuclease
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